Letter To Stephen Muldrow USAFLM Re Dr. Asad Qamar May-12-2017

VIA Email and U.S.
Mail May 12, 2017
W. Stephen Muldrow USAFLM

Acting United States Attorney
Middle District of Florida
U.S. Attorney's Office
400 North Tampa Street, Suite 3200
Tampa, FL 33602
Main Line: 813-274-6000
Fax Line: 813-274-6358
Email: w.stephen.muldrow@usdoj.gov
https://www.justice.gov/usao-mdfl/contact-us
RE: United States v Florida cardiologist Dr. Asad Qamar
Dear U.S. Attorney Muldrow:
Forwarded below is my email December 29, 2015 to Lee Bentley, former USAFLM, about
Dr. Asad Qamars medical negligence/malpractice against my mother, Penelope Gillespie. Also
attached is the West Marion-Ocala Regional hospital bill of $74,095.82 for Ms. Gillespie.
I am pleased to read the attached press release June 30, 2016 where Mr. Bentley obtained a
multi-million dollar settlement from Dr. Qamar.
Unfortunately the Florida Department of Health shows the license status clear/active for Dr.
Asad Qamar (ME73803), even though the attached Administrative Complaint No. 2014-151189
shows wrongdoing. Dr. Qamar violated Fla. Stat. 456.072(1)(bb), signed September 9, 2016 by
Celeste Philip, MD, MPH, Surgeon General and Secretary, Florida Department of Health.
Dr. Qamar committed medical negligence/malpractice when he violated a medical standard of

care by planning a cardioversion for Ms. Gillespie, a 75 year-old female with chronic atrial
fibrillation or A-fib (4+ years). Cardioversion is a operation where the patients heart is
deliberately stopped by the doctor; then an attempt is made to jump-start the heart for the
purpose of restoring the hearts normal rhythm. If the patients heart does not restart, the patient
dies on the operating table.
Dr. Qamar also prescribed the anti-arrhythmic drug Rythmol for home use, which use is
restricted to hospital only. The result was a catastrophe that almost killed Ms. Gillespie.
Subsequently I learned from other cardiologists that Dr. Qamars treatment plan was completely
inappropriate, given the fact that moms A-fib was chronic, 4+ years. Chronic A-fib does not
respond to cardioversion, because after six months or so of arrhythmia the hearts "memory" is
resistant to change. Had the reckless Dr. Qamar proceeded, Ms. Gillespie would likely have died
on the operating table. Without the procedure Ms. Gillespie lived 3+ more years, but never fully
recovered from her adverse reaction to the anti-arrhythmic drug Rythmol, where she became
orthostatic and was hospitalized Dec-06-05 to Dec-23-05 at West Marion Community Hospital.
W. Stephen Muldrow USAFLM May 12, 2017
RE: Dr. Asad Qamar Page - 2
Ms. Gillespies hospitalization was marked by gastrointestinal complications and other issues
and was life threatening. Upon release from the hospital, Ms. Gillespie required inpatient nursing
care from Dec-23-06 to Jan-10-06 at TiberRidge Nursing and Rehabilitation. Then home care.
After Ms. Gillespies release from the nursing home in January 2006, Dr. Qamar persisted with
his treatment plan of anti-arrhythmic drug (now Amiodarone) preparatory to cardioversion, even
after the previous catastrophic sequence of events. I fired Dr. Qamar at that point.
A second opinion determined Dr. Qamars treatment was contraindicated. That cardiologist
successfully treated mom by managing her A-fib. All of Ms. Gillespies other doctors concurred,
including two primary care physicians, her neurologist, and other specialists. My mother lived,
but suffered declining kidney function.
Ms. Gillespie was diagnosed in 2004 and receiving treatment for Alzheimers disease. In my
opinion Ms. Gillespies mental condition deteriorated significantly after Dr. Qamars treatment.
I was primary caregiver for Ms. Gillespie, her attorney in fact, and her healthcare surrogate.
Additional medical records and cost records are available.
Does your office, or the U.S. Department of Justice, plan any action in this matter, initially
submitted December 29, 2015? Thank you in advance for the courtesy of a response.
Sincerely,
Neil J. Gillespie
8092 SW 115th Loop
Ocala, FL 34481
Tel. 352-854-7807
Email: neilgillespie@mfi.net
Attachments/enclosures
Page 1 of 2
Neil Gillespie
From: "Neil Gillespie" <neilgillespie@mfi.net>

To: "Stephen Muldrow" <w.stephen.muldrow@usdoj.gov>
Cc: "Nichole Geary" <nichole.geary@flhealth.gov>; "Florida Health" <health@flhealth.gov>; "Celeste
Philip" <Celeste.Philip@flhealth.gov>; "DOH" <mqa.consumerservices@flhealth.gov>; "Kelli Wells"
<Kelli.Wells@flhealth.gov>; "Alexis Lambert" <Alexis.Lambert@flhealth.gov>; "FBI Tampa Division"
<tampa.division@ic.fbi.gov>; "Neil Gillespie" <neilgillespie@mfi.net>; "Mark Gillespie"
<mark.gillespie@att.net>
Sent: Friday, May 12, 2017 2:00 PM
Attach: 2007, 09-24-07, John H. Piccin Esq.pdf; 2007, 07-24-07, Ranier Munns, John Willis, Esq.pdf; 2007,
08-02-07, Robert W Bauer Esq.pdf; 2007, 08-22-07, Stephen J Knox Esq.pdf; 2007, 08-22-07, Victor
J. Musleh Jr Esq.pdf; 2007, 08-23-07, John Green Esq.pdf; 2007, 08-28-07, Scott R. McMillen
Esq.pdf; 2007, 08-30-07, Martin J. Goldberg Esq.pdf; 3 Amiodarone 200MG Tablets for PMG-
AsadQamarMD 2p.pdf; 1 DrAsad Qamar medical record for Penelope Gillespie-19p.pdf; 2 Rythmol
SR 225MG Capsules for PMG-DrA.Qamar 1p.pdf; medical cost, hospitalization and rehabilitation
$77,991.81.pdf; US Dept of Justice v Dr Asad Qamar.pdf; West Marion-Ocala Regional hospital bill
$74,095.82 Penelope Gillespie 18p..pdf; Florida Cardiologist And His Practice Pay Millions.pdf; Asad
Ullah Qamar License Number ME73803.pdf; ADMINISTRATIVE COMPLAINT CASE NO 2014-
15189, ASAD ULLAH QAMAR, M.D..pdf; Gillespie letter May-12-2017 to Stephen Muldrow USAFLM
re Dr. Asad Qamar.pdf
Subject: Gillespie letter May-12-2017 to Stephen Muldrow USAFLM re Dr. Asad Qamar
Please see attached, Gillespie letter May-12-2017 to Stephen Muldrow USAFLM re Dr. Asad
Qamar.pdf
----- Original Message -----

From: Neil Gillespie
To: Lee Bentley USAFLM ; FBI Tampa Division ; FBI Jacksonville Division
Cc: Neil Gillespie
Sent: Tuesday, December 29, 2015 11:17 AM
Subject: United States v Florida cardiologist Dr. Asad Qamar et al.
A. Lee Bentley, USAFLM

US Attorneys Office, Tampa Florida
Paul Wysopal, Special Agent in Charge

FBI Tampa Division
Michelle S. Klimt, Special Agent in Charge

FBI Jacksonville Division
RE: United States v Florida cardiologist Dr. Asad Qamar et al.
My mother Penelope M. Gillespie was a patient of Florida cardiologist Dr. Asad Qamar in 2005-2006.
Attached you find Dr. Asads medical records for Ms. Gillespie, and prescriptions written by Dr. Asad
for Ms. Gillespie.
Also attached is my written communication with eight (8) attorneys who reviewed what I believe was
medical malpractice by Dr. Asad, his planned cardioversion for Ms. Gillespie for chronic atrial
fibrillation. I stopped the cardioversion, which likely would have killed my mother. Ms. Gillespies
adverse reaction to the drug Rythmol SR 225 MG left her hospitalized and near death. The cost of Ms.
Gillespies hospitalization and rehabilitation was at least $77,991.81. Medicare and private insurance
covered most, if not all of the cost. Thank you.
5/14/2017
Page 2 of 2
Sincerely,
Neil J. Gillespie
8092 SW 115th Loop
Ocala, Florida 34481
Tel. 352-854-7807
5/14/2017
https://www.justice.gov/usao-mdfl/pr/florida-cardiologist-and-his-practice-pay-millions-and-agree-three-years-exclusion
SEARCH
HOME ABOUT NEWS MEET THE U.S. ATTORNEY PROGRAMS RESOURCES JOBS CONTACT
U.S. Attorneys Middle District of Florida News
Department of Justice
U.S. Attorneys Office
Middle District of Florida
FOR IMMEDIATE RELEASE Thursday, June 30, 2016
Florida Cardiologist And His Practice Pay Millions And Agree To Three
Years Of Exclusion To Resolve Alleged False Billings For Unnecessary
Procedures And Illegal Kickbacks
Tampa, FL An Ocala, Florida, cardiologist, Dr. Asad Qamar, and his practice, the Institute of Cardiovascular
Excellence (ICE), will pay $2 million, plus release any claim to $5.3 million in suspended Medicare funds, to resolve a
lawsuit alleging that they improperly billed Medicare, Medicaid and TRICARE for medically unnecessary procedures,
and paid kickbacks to patients by waiving Medicare copayments irrespective of financial hardship, the Justice
Department announced today. Dr. Qamar also agreed to a three-year period of exclusion from participating in any
federal health care program followed by a three-year Integrity Agreement with the Department of Health and Human
Services Office of the Inspector General (HHS-OIG). The settlement relates to two consolidated lawsuits in which the
United States intervened on Dec. 22, 2014.
Patient safety is of paramount importance, said U.S. Attorney A. Lee Bentley III for the Middle District of Florida.
When a doctor performs medically unnecessary and invasive procedures on Medicare patients, federal healthcare
programs are defrauded and, more importantly, patients lives and wellbeing are recklessly put at risk. This case
shows our offices steadfast commitment to holding medical providers personally responsible for their actions.
Billing federal health programs for medically unnecessary procedures is unacceptable not only does it waste
taxpayer funds, but it also puts patients at risk, said Principal Deputy Assistant Attorney General, Benjamin C. Mizer,
head of the Justice Departments Civil Division. Todays settlement evidences the Department of Justices firm
commitment to protect public funds and to safeguard the well-being of federal health care program beneficiaries.
The settlement resolves the governments lawsuit claiming that Dr. Qamar and ICE billed Medicare, Medicaid and
TRICARE for excessive, medically unnecessary and inadequately documented peripheral artery interventional
services and related procedures. Many of the cardiovascular procedures for which Dr. Qamar and ICE billed
Medicare and the other programs were not indicated by patients medical histories or records, or the severity of the
patients symptoms.
The government also alleged that to help facilitate this false billing scheme, Dr. Qamar and ICE routinely and
indiscriminately waived the 20 percent Medicare copayment, irrespective of the patients financial need. Medicare
copayments assure that patients have an incentive to be smart healthcare consumers and avoid unnecessary
procedures. By waiving the required copayments indiscriminately, Dr. Qamar and ICE induced patients to agree to
unnecessary and invasive procedures and other services. Dr. Qamars and ICEs illegal conduct made Dr. Qamar the
highest paid Medicare cardiologist in the country in 2012 and 2013.
https://www.justice.gov/usao-mdfl/pr/florida-cardiologist-and-his-practice-pay-millions-and-agree-three-years-exclusion
When medical professionals act on greed to perform unnecessary, invasive procedures on Medicare and Medicaid
patients, both patient health and taxpayer funds are compromised, said Special Agent in Charge Shimon R. Richmond
of HHS-OIG. Our agents and investigators will continue to work hard with our law enforcement partners to ensure
that health care providers who engage in such illegal behavior are held accountable.
The allegations resolved by todays settlement were originally raised in two lawsuits filed pursuant to the qui tam, or
whistleblower, provisions of the False Claims Act, which permit private parties to sue on behalf of the government
when they discover evidence that defendants have submitted false claims for government funds and to receive a
share of any recovery. The False Claims Act also permits the government to intervene in such lawsuits, as it has
done in these cases. The cases are captioned United States ex rel. Doe v. Institute of Cardiovasular Excellence,
PLLC, ICE Holdings, PLLC, Dr. Asad Qamar, & Dr. Humera Qamar, Case No. 5:11-CV-406-OC-KRS (M.D. Fla.);
United States ex rel. Taylor & the State of Florida v. Institute of Cardiovascular Excellence & Dr. Asad Qamar, Case
No. 8:14-CV-1454-T-35-EAS (M.D. Fla.). The relators Dr. Robert A. Green and Ms. Holly A. Taylor will receive
$1,327,721 as their share of the settlement.
This settlement illustrates the governments emphasis on combating health care fraud and marks another achievement
for the Health Care Fraud Prevention and Enforcement Action Team (HEAT) initiative, which was announced in May
2009 by the Attorney General and the Secretary of Health and Human Services. The partnership between the two
departments has focused efforts to reduce and prevent Medicare and Medicaid financial fraud through enhanced
cooperation. One of the most powerful tools in this effort is the False Claims Act. Since January 2009, the Justice
Department has recovered a total of more than $29.9 billion through False Claims Act cases, with more than $18.3
billion of that amount recovered in cases involving fraud against federal health care programs.
This case was handled by the Commercial Litigation Branch of the Department of Justices Civil Division, the U.S.
Attorneys Office for the Middle District of Florida, HHS-OIG, and the Defense Health Agency on behalf of the
TRICARE program. The claims asserted by the government are allegations only, and there has been no determination
of liability.
Topic(s): Component(s):
Healthcare Fraud USAO - Florida, Middle
Updated June 30, 2016

https://appsmqa.doh.state.fl.us/MQASearchServices/HealthcareProviders/LicenseVerificationPractitionerPrintFriendly?LicInd=64677&Procde=1501
Department of Health
ASAD ULLAH QAMAR
License Number: ME73803

Data As Of 4/20/2017
Profession Medical Doctor
License ME73803
License Status CLEAR/ACTIVE
Qualifications Dispensing Practitioner
License Expiration Date 1/31/2019
License Original Issue Date 08/01/1997
Address of Record 4730 SW 49TH ROAD
OCALA, FL 34474-6262
UNITED STATES
Controlled Substance Prescriber No
Discipline on File No
Public Complaint Yes
The information on this page is a secure, primary source for license verification provided by the Florida
Department of Health, Division of Medical Quality Assurance. This website is maintained by Division staff and is
updated immediately upon a change to our licensing and enforcement database.
STATE OF FLORIDA
DEPARTMENT OF HEALTH
DEPARTMENT OF HEALTH,
PETITIONER,
v. CASE NO.: 2014-15189
ASAD ULLAH QAMAR, M.D.,
RESPONDENT.
ADMINISTRATIVE COMPLAINT
Petitioner Department of Health files this Administrative Complaint before the
Board of Medicine against Respondent Asad Ullah Qamar, M.D., and in support thereof
alleges:
1. Petitioner is the state agency charged with regulating the practice of
medicine pursuant to Section 20.43, Florida Statutes; Chapter 456, Florida Statutes; and
Chapter 458, Florida Statutes.
2. At all times material to this Complaint, Respondent was a licensed physician
within the State of Florida, having been issued license number ME 73803.
3. Respondent's address of record is 4730 SW 49th Road, Ocala, Florida 34474.
4. On or about August 27, 2014, Patient A.P. presented to the Institute for
Cardiovascular Excellence ("ICE") for treatment of a high grade lesion in the left anterior
tibial artery.
5. On or about August 29, 2014, Respondent performed a balloon angioplasty
and atherectomy procedure on Patient A.P.

6. The billing code utilized by Respondent for the procedure was 440.21, which
is used to indicate 'intermittent claudication.'
7. Respondent performed a CT scan and angiogram of Patient A.P.'s legs,
neither of which revealed a blockage nor any indication that Patient A.P. suffered from
intermittent claudication.
8. The balloon angioplasty and atherectomy procedure performed on Patient
A.P. was not medically necessary.
9. Section 456.072(1)(bb), Florida Statutes (2014), provides that performing
or attempting to perform health care services on the wrong patient, a wrong-site
procedure, a wrong procedure, or an unauthorized procedure or a procedure that is
medically unnecessary or otherwise unrelated to the patient's diagnosis or medical
condition is grounds for disciplinary action by the Board of Medicine.
12. On or about August 29, 2014, Respondent violated Section 456.072(1)(bb),
Florida Statutes (2014), by performing or attempting to perform a medically unnecessary
procedure by performing a balloon angioplasty and atherectomy on Patient A.P.
13. Based on the foregoing, Respondent violated Section 456.072(1)(bb),
Florida Statutes (2014), by performing or attempting to perform a procedure that is
medically unnecessary.
WHEREFORE, the Petitioner respectfully requests that the Board of Medicine enter
an order imposing one or more of the following penalties: permanent revocation or
suspension of Respondent's license, restriction of practice, imposition of an administrative
fine, issuance of a reprimand, placement of the Respondent on probation, corrective
2 of 5
DOH V. ASAD ULLAH QAMAR M.D., DOH CASE NO. 2014-15189
action, refund of fees billed or collected, remedial education and/or any other relief that
the Board deems appropriate.
SIGNED this day of , 2016
Celeste Phillip, MD, MPH

Surgeon General and
Secretary of Health
Peter Delia
Assistant General Counsel
FILED DOH Prosecution Services Unit
DEPARTMENT OF HEALTH 4052 Bald Cypress Way, Bin C-65
DEPUTY CLERK Tallahassee, FL 32399-3265
Florida Bar No. 104207
CLERK: 1114441) &WAS (850) 245-4444 Telephone
(850) 245-4684 FAX
DATE 1/6/1/111 Peter.Delia@fihealth.gov
PVD/bf
PCP Date: September 9, 2016
PCP Members: Dr. Avila, Dr. Ginzburg, Mr. Romanello
3 of 5
DOH V. ASAD ULLAH QAMAR M.D., DOH CASE NO. 2014-15189
DOH V. ASAD ULLAH QAMAR, M.D., DOH CASE NO. 2014-15189
NOTICE OF RIGHTS
Respondent has the right to request a hearing to be conducted

in accordance with Section 120.569 and 120.57, Florida Statutes,
to be represented by counsel or other qualified representative, to
present evidence and argument, to call and cross-examine
witnesses and to have subpoena and subpoena duces tecum issued
on his or her behalf if a hearing is requested. A request or petition
for an administrative hearing must be in writing and must be
received by the Department within 21 days from the day
Respondent received the Administrative Complaint, pursuant to
Rule 28-106.111(2), Florida Administrative Code. If Respondent
fails to request a hearing within 21 days of receipt of this
Administrative Complaint, Respondent waives the right to request
a hearing on the facts alleged in this Administrative Complaint
pursuant to Rule 28-106.111(4) Florida Administrative Code. Any
request for an administrative proceeding to challenge or contest
the material facts or charges contained in the Administrative
Complaint must conform to Rule 28-106.2015(5), Florida
Administrative Code.
Mediation under Section 120.573, Florida Statutes, is not

available to resolve this Administrative Complaint.
OTICE REGARDING ASSESSMENT OF COSTS
Respondent is placed on notice that Petitioner has incurred

costs related to the investigation and prosecution of this matter.
Pursuant to Section 456.072(4)1 Florida Statutes, the Board shall
assess costs related to the investigation and prosecution of a
disciplinary matter, which may include attorney hours and costs,
on the Respondent in addition any other discipline imposed.
4 of 5
DOH V. ASAD ULLAH QAMAR M.D., DOH CASE NO. 201445189
~ATIENT NO: 86604215 OCALA REGIONAL MED CTR BILLING DATE PAGE 1 00050
MED REC NO: 170343 P.O. BOX 406549 12/28/05
GUARANTOR NO: ATLANTA, GA 30384-6549
PATIENT: 352-401-1120 ADMITTED DISCHARGED
GILLESPIE PENELOPE M 12/06/05 12/23/05
BILL TO:
GILLESPIE PENELOPE M INPATIENT FC=Ol
8092 SW 115TH LOOP ADMIT THRU DISCHARGE CLAIM
OCALA FL
34481
DATE OF ATT SERV REV

SERVICE PHYS FC ROOM AC CODE CODE DEPT ROOM AND CARE CHARGES
12/06/05 483 01 3311A P MSWM 110 0623 17 DAYS AT 700.00 11,900.00
TOTAL ROOM AND CARE 11,900.00

DATE OF BATCH F NDC/CPT-4/
SERVICE REF DEPT S PROC HCPCS QTY SERVICE DESCRIPTION CHARGES
250-PHARMACY
120605 07B389 0712 101660 182133089 4 METRONIDAZOLE .25G T 39.00
120605 07B389 0712 124723 85026381 4 KCL 10MEQ SA TAB 34.00
120705 07B472 0712 125234 338070541 3 KCL 10MEQ/50ML SOLN 897.75
120705 07B437 0712 126322 74672723 2 MAGNESIUM SULF 1GM/100 81.00
120705 07B437 0712 125234 338070541 3 KCL 10MEQ/50ML SOLN 897.75
120705 07B437 0712 125234 338070541 1 KCL 10MEQ/50ML SOLN 299.25
120705 07B436 0712 125419 45152010 1 LEVOFLOXACIN 250MG 62.75
120705 07B471 0712 124723 85026381 4 KCL 10MEQ SA TAB 34.00
120705 07B398 0712 124723 85026381 4 KCL 10MEQ SA TAB 34.00
120805 08B615 0712 124723 85026381 4 KCL 10MEQ SA TAB 34.00
120805 08B615 0712 123800 904404073 2 ASA 81MG 2.00
120805 08B617 0712 124723 85026381 4 KCL 10MEQ SA TAB 34.00
120805 08B609 0712 112561 703537204 2 MAG. S04 1GM/2ML VL 57.00
120805 08B609 0712 124723 85026381 4 KCL 10MEQ SA TAB 34.00
120805 08B594 0715 125644 338067104 1 D5-1/2NS 1L/KCL20MEQ 190.00
120805 08B523 0712 124723 85026381 4 KCL 10MEQ SA TAB 34.00
120805 08B523 0712 124723 85026381 3 KCL 10MEQ SA TAB 25.50
120805 09B712 0712 124723 85026381 3 KCL 10MEQ SA TAB 25.50
120905 09B707 0715 125644 338067104 2 D5-1/2NS 1L/KCL20MEQ 380.00
A FOR-PROFIT, TAX PAYING HOSPITAL LICENSED BY THE

STATE OF FLORIDA IRS 59-1479652.
,
PATIENT NO: 86604215 OCALA REGIONAL MED CTR BILLING DATE PAGE 2 00050
MED REC NO: 170343 P.O. BOX 406549 12/28/05

120905 09B707 0712 111106 60977000101 1 PROMETHAZIN 25MG AMP 91.25

120905 09B707 0712 124723 85026381 4 KCL 10MEQ SA TAB 34.00
120905 09B641 0712 124723 85026381 8 KCL 10MEQ SA TAB 68.00
120905 09B641 0712 123800 904404073 1 ASA 81MG 1.00
121005 10B746 0712 124723 85026381 4 KCL 10MEQ SA TAB 34.00
121005 10B746 0712 123800 904404073 1 ASA 81MG 1.00
121005 10B781 0712 126322 74672723 2 MAGNESIUM SULF 1GM/100 81.00
121005 28J605 0712 101660 182133089 2 METRONIDAZOLE .25G T 19.50
121105 11B820 0712 123800 904404073 1 ASA 81MG 1.00
121105 11B840 0712 103173 51641021411 2 IBUPROFEN 400MG TAB 32.00
121205 12B899 0712 123800 904404073 1 ASA 81MG 1.00
121305 13B025 0712 123800 904404073 1 ASA 81MG 1.00
121305 13B064 0712 116576 52268010001 1 COLYTELY 4000ML BTL 162.75
121305 13B097 0712 125233 338045102 1 HEPARIN 25000U/D5W 250 77.75
121305 13B097 0712 125233 338045102 1 HEPARIN 25000U/D5W 250 77.75
121405 14B153 0712 123800 904404073 1 ASA 81MG 1.00
121405 14B229 0712 125233 338045102 1 HEPARIN 25000U/D5W 250 77.75
121405 14B153 0712 125233 338045102 1 HEPARIN 25000U/D5W 250 77.75
121505 15B323 0712 107553 132010915 1 FLEET PHOSPHO SODA 2.75
121505 15B279 0712 123800 904404073 1 ASA 81MG 1.00
121605 16B400 0712 123800 904404073 1 ASA 81MG 1.00
121605 16B432 0712 123909 8060202 1 MEPERIDINE 50MG VL 110.25

MED REC NO: 170343 P.O. BOX 406549 12/28/05

121605 16B432 0712 124630 4199806 1 MIDAZOLAM 2MG VIAL 105.25

121605 16B459 0712 123800 904404073 1 ASA 81MG 1.00
121705 17B528 0712 114198 74665106 2 KCL 20MEQ VIAL 94.50
121805 18B564 0712 114198 74665106 2 KCL 20MEQ VIAL 94.50
121905 19B705 0712 114198 74665106 2 KCL 20MEQ VIAL 94.50
121905 19B700 0712 114198 74665106 1 KCL 20MEQ VIAL 47.25
121905 19B638 0712 114198 74665106 2 KCL 20MEQ VIAL 94.50
122005 20B750 0712 114198 74665106 2 KCL 20MEQ VIAL 94.50
122105 21B929 0715 126190 338111304 1 CLINIMIX-E 2L 1020.25
122105 21B929 0712 101671 51079064420 1 CYCLOBENZAPRINE 10MG 22.50
122105 21B935 0712 114198 74665106 2 KCL 20MEQ VIAL 94.50
122105 21B869 0712 114198 74665106 2 KCL 20MEQ VIAL 94.50
122205 21B929 0715 126190 338111304 1 CLINIMIX-E 2L 1020.25
122205 22B019 0715 126190 338111304 1 CLINIMIX-E 2L 1020.25
122205 22B019 0715 126190 338111304 1 CLINIMIX-E 2L 1020.25
122205 22B039 0712 124011 641243645 2 HEP-LOCK100U/ML 10ML 42.50
122205 22B039 0712 126325 59747011297 2 NS FLUSH 10ML SYRINGE 7.50
122205 22B978 0715 126190 338111304 1 CLINIMIX-E 2L 1020.25
122305 23B136 0712 124011 641243645 2 HEP-LOCK100U/ML 10ML 42.50
122305 23B135 0712 124462 45045104 1 APAP 500MG TAB 1.00
122305 24B210 0712 124011 641243645 2 HEP-LOCK100U/ML 10ML 42.50
122305 28J605 0712 101671 51079064420 1 CYCLOBENZAPRINE 10MG 22.50
122305 28J605 0712 101671 51079064420 1 CYCLOBENZAPRINE 10MG 22.50
SUBTOTAL: 6469.75
255-DRUGS/INCIDENT RAD
121605 16B434 0712 127027 A4646 1 LOCM 300-399 MG 957.00
121905 19B702 0712 127021 A4645 1 LOCM 200-299 MG 792.00
122205 22B040 0712 127021 A4645 1 LOCM 200-299 MG 792.00
SUBTOTAL: 2541.00
258-IV SOLUTIONS
120705 07B468 0715 001436 1 SOL NS 1000 171.00

MED REC NO: 170343 P.O. BOX 406549 12/28/05

120705 07B468 0715 001436 1 SOL NS 1000 171.00

120805 08B609 0715 124533 338001738 1 D5W 100ML 223.00
121405 15B277 0715 001436 1 SOL NS 1000 171.00
121505 15B318 0718 001435 2 SOL NS 500 285.50
121705 17B528 0715 124546 338008904 2 D5NS 1000ML 592.50
121805 18B564 0715 124546 338008904 2 D5NS 1000ML 592.50
121905 19B705 0715 124546 338008904 2 D5NS 1000ML 592.50
121905 19B700 0715 124546 338008904 1 D5NS 1000ML 296.25
121905 19B638 0715 124546 338008904 2 D5NS 1000ML 592.50
122005 20B750 0715 124546 338008904 2 D5NS 1000ML 592.50
122105 21B935 0715 124546 338008904 2 D5NS 1000ML 592.50
122105 21B869 0715 124546 338008904 2 D5NS 1000ML 592.50
SUBTOTAL: 3095.25
259-0THER PHARMACY
120605 07B389 0712 123405 85175801 2 CIPROFLOX 250MG TAB 62.00
120605 07B389 0712 124577 56017275 1 WARFARIN 5MG TAB 5.50
120605 07B389 0712 125514 62856024541 4 DONEPEZIL 5MG TAB 183.00
120705 07B403 0712 124577 56017275 1 WARFARIN 5MG TAB 5.50
120705 07B436 0712 126249 456320560 2 MEMANTINE 5MG TAB 28.00
120705 07B436 0712 124601 74162812 1 PROPAFENONE 150MGTAB 5.50
120705 07B471 0712 102661 51079006720 2 DIPHENOX/ATROPIN TAB 11.00
120805 08B615 0712 105982 235010501 2 LACTOBACILLUS CAP 11.00
120805 08B615 0712 125754 65726023510 2 ISRADIPINE CR 5MG TAB 27.50
120805 08B615 0712 102650 781137113 2 METOPROLOL 50MG TAB 12.00
120805 08B615 0712 125517 83400001 4 VALSARTAN 80MG TAB 55.00
120805 08B615 0712 124429 245009001 2 MULTIVIT TAB 2.00
120805 08B615 0712 125592 182101701 2 CYANOCOBALAMIN1MGTAB 4.00
120805 08B564 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
120805 08B564 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50

MED REC NO: 170343 P.O. BOX 406549 12/28/05
GUARANTOR NO: ATLANTA. GA 30384-6549

120905 09B707 0712 125601 182003701 1 CYANOCOBALAMIN500MCG 1.00
120905 09B641 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
120905 09B641 0712 124429 245009001 1 MULTIVIT TAB 1.00
121005 10B769 0712 125601 182003701 1 CYANOCOBALAMIN500MCG 1.00
121005 10B746 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121005 10B746 0712 124429 245009001 1 MULTIVIT TAB 1.00
121005 10B746 0712 125601 182003701 1 CYANOCOBALAMIN 5 0 OMCG 1.00
121005 10B762 0712 125592 182101701 1 CYANOCOBALAM IN1 MGTAB 2.00
121005 10B785 0712 124576 56017675 1 WARFARIN 2.5MG TAB 5.50
121005 10B781 0712 124576 56017675 1 WARFARIN 2.5MG TAB 5.50
121005 10B781 0712 124170 364238990 4 PRAZOSIN 1MG CAP 22.00
121005 10B781 0712 125497 2510501 3 VANC050MG/MLSYRUP5ML 117.75
121005 10B781 0712 124128 165002241 1 MAGNESIUM 250MG TAB 8.50
A FOR-PROFIT. TAX PAYING HOSPITAL LICENSED BY THE

MED REC NO: 170343 P.O. BOX 406549 12/28/05
3ILLESPIE PENELOPE M 12/06/05 12/23/05


121105 11B820 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121105 11B820 0712 124429 245009001 1 MULTIVIT TAB 1.00
121105 11B820 0712 124170 364238990 4 PRAZOSIN 1MG CAP 22.00
121105 11B843 0712 124170 364238990 2 PRAZOSIN 1MG CAP 11.00
121105 28J605 0712 124170 364238990 1 PRAZOSIN IMG CAP 11.00
121105 28J605 0712 102650 781137113 1 METOPROLOL 50MG TAB 6.00
121205 12B946 0712 124170 364238990 4 PRAZOSIN 1MG CAP 22.00
121205 12B899 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121205 12B899 0712 124429 245009001 1 MULTIVIT TAB 1.00
121205 12B899 0712 124170 364238990 4 PRAZOSIN 1MG CAP 22.00
121205 12B946 0712 124170 364238990 2 PRAZOSIN 1MG CAP 11.00
121205 12B942 0712 102661 51079006720 1 DIPHENOx/ATROPIN TAB 5.50
121205 28J605 0712 125497 2510501 1 VANC050MG/MLSYRUP5ML 39.25
121205 28J605 0712 124170 364238990 2 PRAZOSIN 1MG CAP 11.00
121305 13BI03 0712 125517 83400001 2 VALSARTAN 80MG TAB 27.50
121305 13BI03 0712 125754 65726023510 1 ISRADIPINE CR 5MG TAB 13.75

MED REC NO: 170343 P.O. BOX 406549 12/28/05
SILLESPIE PENELOPE M 12/06/05 12/23/05

121305 13B025 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121305 13B025 0712 124429 245009001 1 MULTIVIT TAB 1.00
121405 14B153 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121405 14B153 0712 124429 245009001 1 MULTIVIT TAB 1.00
121505 15B320 0712 124716 37000074107 1 PSYLLIUM PACKET 1.00
121505 15B350 0712 124592 49342041 2 FLUCONAZOLE 100MG TB 98.50
121505 15B350 0712 109180 3059320 1 NYSTATIN 15GM POWDER 70.75
121505 15B279 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121505 15B279 0712 124429 245009001 1 MULTIVIT TAB 1.00

MED REC NO: 170343 P.O. BOX 406549 12/28/05


121505 16B436 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121605 16B400 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121605 16B400 0712 124429 245009001 1 MULTIVIT TAB 1.00
121605 28J605 0712 125517 83400001 2 VALSARTAN 80MG TAB 27.50
121705 17B496 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121705 17B496 0712 124429 245009001 1 MULTIVIT TAB 1.00

MED REC NO: 170343 P.O. BOX 406549 12/28/05


121705 18B586 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121805 18B564 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121805 18B564 0712 124429 245009001 1 MULTIVIT TAB 1.00
121905 19B638 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
121905 19B638 0712 124429 245009001 1 MULTIVIT TAB 1.00
122005 20B750 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
122005 20B750 0712 124429 245009001 1 MULTIVIT TAB 1.00
122005 28J605 0712 126249 456320560 2 MEMANTINE 5MG TAB 28.00
122105 21B929 0712 124240 131422086 2 FE POLYSAC 150MG CAP 9.00
122105 21B869 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
122105 21B869 0712 124429 245009001 1 MULTIVIT TAB 1.00

~ED REC NO: 170343 P.O. BOX 406549 12/28/05


122205 22B978 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
122205 22B978 0712 124429 245009001 1 MULTIVIT TAB 1.00
122305 23B140 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
122305 23B140 0712 124429 245009001 1 MULTIVIT TAB 1.00
122305 23B083 0712 100830 173024256 1 DIGOXIN 0.125MG 5.50
122305 23B083 0712 124429 245009001 1 MULTIVIT TAB 1.00
SUBTOTAL: 5037.00
270-MED SURG SUPPLIES
120605 07B468 0718 001286 1 DIAL A FLO 73.50
120605 07B468 0718 043726 1 IL,I.V. SET LOOP 38.75
120605 07B468 0718 043721 1 IL,I.V. SET, 10 DROP 86.25
120705 07B468 0718 001095 1 BULKY BANDAGE 32.25
120705 07B468 0718 001068 1 AQUAPHOR 3 X 3 24.25
120705 07B468 0718 001069 1 AQUAPHOR 8 X 3 24.25
121205 12B966 0718 299511 1 IV START KIT W/CHORA 19.00

MED REC NO: 170343 P.O. BOX 406549 12/28/05
121205 12B966 0718 043726 1 IL.I.V. SET LOOP 38.75
121205 12B966 0718 301067 1 CATH IV PROTEcr 22 X 1 25.50
121305 13B094 0718 043722 1 IL.I.V. SET 60 DROP 35.25
121305 13B094 0718 043726 1 IL.I.V. SET LOOP 38.75
121405 15B277 0718 043721 1 IL.I.V. SET. 10 DROP 86.25
121505 15B318 0718 001182 1 02 CANNULA 46.50
121505 15B318 0718 043731 1 IL.I.V. SET. CONT, FLO 131.75
121505 15B318 0718 043728 1 IL. I. V. SET. PRN INJE 29.75
121605 16B457 0718 001489 1 URETHRAL TRAY 59.50

121605 16B452 0718 001489 1 URETHRAL TRAY 59.50
121605 16B452 0718 221645 1 FOLEY CATH-SILVER TRA9 64.00
121605 16B452 0718 001030 1 CATHETER LEG STRAP 33.00
121705 18B593 0718 043726 1 IL.I.V. SET LOOP 38.75
121805 18B593 0718 001370 1 BLOOD SET 2C2027 20.00
122005 20B813 0718 043726 1 IL.I.V. SET LOOP 38.75
122105 21B925 0718 043546 1 PAD. DUOTHERM 12X14 267.75
122105 21B925 0718 043721 1 IL.I.V. SET. 10 DROP 86.25
122105 21B925 0718 043723 1 IV SECONDARY SET 5.25
SUBTOTAL: 1673.50
272-STERILE SUPPLY
121605 16B452 0718 008146 1 CATH FOLEY 5CC 16 29.75
SUBTOTAL: 29.75
30 a-LABORATORY
120705 07B434 0737 900829 80074 1 ACUTE HEPATITIS PANEL 32.19
SUBTOTAL: 32.19
30 I-LAB/CHEMISTRY
120605 06B360 0736 800531 80053 1 COMP METABOLIC PANEL 576.75
120705 07B434 0736 800481 80048 1 BASIC METABOLIC PANEL 461.75
120705 07B434 0736 837351 83735 1 MAGNESIUM BLD 209.50

~ED REC NO: 170343 P.O. BOX 406549 12/28/05

120705 07B434 0736 844391 84439 1 T4 FREE 97.00

120705 07B434 0736 844431 84443 1 TSH 201.00
120705 07B434 0736 835401 83540 1 IRON 49.50
120705 07B434 0736 827281 82728 1 FERRITIN 151.75
120805 08B529 0737 900142 82105 1 ALPHA FETOPROT SERUM M 8.00
120805 08B597 0736 837351 83735 1 MAGNESIUM BLD 209.50
120805 08B556 0736 825501 82550 1 CREAT KINASE (CK) TOTA 120.50
120805 08B556 0736 825531 82553 1 CK MB 152.00
120805 08B556 0736 844841 84484 1 TROPONIN QUANT 140.00
120805 08B521 0736 837351 83735 1 MAGNESIUM BLD 209.50
120805 08B589 0736 825531 82553 1 CK MB 152.00
120805 08B589 0736 844841 84484 1 TROPONIN QUANT 140.00
120805 08B589 0736 837351 83735 1 MAGNESIUM BLD 209.50
120805 08B521 0737 900172 82105 1 ALPHA FETOPROT SERUM 13.39
120805 08B516 0737 900142 82105 1 ALPHA FETOPROT SERUM M 8.00
120805 08B516 0736 825531 82553 1 CK MB 152.00
120805 08B516 0736 844841 84484 1 TROPONIN QUANT 140.00
120805 08B516 0737 900174 83516 1 MITOCHONDRIAL AB QL EI 11.31
120905 09B639 0736 829771 82977 1 GAMMA GT 97.25
120905 09B639 0736 837351 83735 1 MAGNESIUM BLD 209.50
120905 09B639 0736 841341 84134 1 PREALBUMIN 79.25
121005 10B739 0736 837351 83735 1 MAGNESIUM BLD 209.50
121105 11B813 0736 800761 80076 1 HEPATIC FUNCTION PANEL 506.50
121105 11B813 0736 837351 83735 1 MAGNESIUM BLD 209.50
121705 17B511 0736 082803 82803 1 ABG WITH CALC 02 SAT 265.50
122005 20B743 0736 826431 80162 1 DIGOXIN (LANOXIN) QN 143.50
SUBTOTAL: 10246.95

MED REC NO: 170343 P.O. BOX 406549 12/28/05
302-LAB/IMMUNOLOGY
120805 08B516 0737 900160 86038 1 ANA QUAL SCREEN 5.64
120805 08B516 0737 901950 86235 1 SMITH ANTIBODY 8.27
120805 08B516 0737 901951 86235 1 RNP ANTIBODY 8.27
121605 28J614 0758 042700 86900 1 ABO TYPE 12.00
121605 28J614 0758 042701 86901 1 RH TYPE 12.00
121605 28J614 0758 042764 86885 1 INDIRECT COOMBS EA AG 24.00
121605 28J614 0758 042514 86920 2 CROSSMATCH IMM SPIN 76.00
121805 18B554 0736 861411 86141 1 C-REACTIVE PROTEIN HS 62.25
SUBTOTAL: 208.43
305-LAB/HEMATOLOGY
120605 06B360 0736 850251 85025 1 CBC PLATELET AUTO DIFF 218.25
120605 07B387 0736 856101 85610 1 PROTIME 139.00
120605 07B387 0736 857301 85730 1 PTT 172.75
120705 08B512 0736 856101 85610 1 PROTIME 139.00
120705 08B512 0736 857301 85730 1 PTT 172.75
120805 08B516 0736 856101 85610 1 PROTIME 139.00
120805 08B516 0736 857301 85730 1 PTT 172.75
120805 09B630 0736 856101 85610 1 PROTIME 139.00
120805 09B630 0736 857301 85730 1 PTT 172.75
120905 09B639 0736 856101 85610 1 PROTIME 139.00
120905 10B735 0736 856101 85610 1 PROTIME 139.00
120905 10B735 0736 857301 85730 1 PTT 172.75
121005 10B739 0736 856101 85610 1 PROTIME 139.00
121105 IlB824 0736 856101 85610 1 PROTIME 139.00
121105 IlB813 0736 850251 85025 1 CBC PLATELET AUTO DIFF 218.25
121105 IlB813 0736 856101 85610 1 PROTIME 139.00
121105 IlB813 0736 856101 85610 1 PROT I ME 139.00
121105 IlB813 0736 857301 85730 1 PTT 172.75
121205 12B893 0736 856101 85610 1 PROTIME 139.00
121305 13B017 0736 856101 85610 1 PROTIME 139.00
121305 14B142 0736 857301 85730 1 PTT 172.75
121405 14B221 0736 857301 85730 1 PTT 172.75
121405 14B151 0736 857301 85730 1 PTT 172.75
121405 14B146 0736 856101 85610 1 PROTIME 139.00
121405 15B267 0736 857301 85730 1 PTT 172.75
121505 15B271 0736 856101 85610 1 PROTIME 139.00

MED REC NO: 170343 P.O. BOX 406549 12/28/05
gILLESPIE PENELOPE M 12/06/05 12/23/05

121605 16B451 0736 850181 85018 1 HEMOGLOBIN 39.50
121605 16B451 0736 850141 85014 1 HEMATOCRIT 32.75
121605 16B393 0736 856101 85610 1 PROTIME 139.00
121705 17B525 0736 850181 85018 1 HEMOGLOBIN 39.50
121705 17B525 0736 850141 85014 1 HEMATOCRIT 32.75
121705 17B536 0736 850181 85018 1 HEMOGLOBIN 39.50
121705 17B536 0736 850141 85014 1 HEMATOCRIT 32.75
121705 17B486 0736 856101 85610 1 PROTIME 139.00
121705 17B494 0736 850141 85014 1 HEMATOCRIT 32.75
121805 18B592 0736 850181 85018 1 HEMOGLOBIN 39.50
121805 18B592 0736 850141 85014 1 HEMATOCRIT 32.75
121805 18B562 0736 850181 85018 1 HEMOGLOBIN 39.50
121805 18B562 0736 850141 85014 1 HEMATOCRIT 32.75
121805 18B554 0736 856101 85610 1 PROTIME 139.00
121905 19B672 0736 850181 85018 1 HEMOGLOBIN 39.50
121905 19B672 0736 850141 85014 1 HEMATOCRIT 32.75
121905 19B717 0736 850181 85018 1 HEMOGLOBIN 39.50
121905 19B717 0736 850141 85014 1 HEMATOCRIT 32.75
121905 19B632 0736 850181 85018 1 HEMOGLOBIN 39.50
121905 19B632 0736 850141 85014 1 HEMATOCRIT 32.75
121905 19B696 0736 850181 85018 1 HEMOGLOBIN 39.50
121905 19B696 0736 850141 85014 1 HEMATOCRIT 32.75
122005 20B743 0736 850181 85018 1 HEMOGLOBIN 39.50
122005 20B743 0736 850141 85014 1 HEMATOCRIT 32.75
122205 22B061 0736 850481 85048 1 WBC COUNT BLD AUTO 23.00
122205 22B055 0736 850481 85048 1 WBC COUNT BLD AUTO 23.00
SUBTOTAL: 6750.25
306-LAB BACTERIOLOGY/MICRO
120705 08B521 0736 872052 87205 1 SMEAR WBC STAIN 172.00
120705 08B521 0736 878031 87803 1 C DIFFICILE TOXIN A 01 124.00
120705 08B521 0736 870461 '* 87046 1 CULT STL ADD'L PATHOGE 81.50
120705 08B521 0736 870451 87045 1 CULTURE STOOL 202.50
120905 09B702 0736 871771 87177 1 O&P SMEAR CONC ID 209.25

MED REC NO: 170343 P.O. BOX 406549 12/28/05


120905 10B760 0736 870461 * 87046 1 CULT STL ADD'L PATHOGE 81.50
120905 10B760 0736 870451 87045 1 CULTURE STOOL 202.50
122205 22B055 0736 870461 * 87046 1 CULT STL ADD'L PATHOGE 81.50
122205 22B055 0736 870451 87045 1 CULTURE STOOL 202.50
122205 22B055 0736 871771 87177 1 O&P SMEAR CONC ID 209.25
122205 22B055 0736 872052 87205 1 SMEAR WBC STAIN 172.00
122205 25B255 0736 871862 87186 1 SUSC MIC 180.75
122205 25B244 0736 871862 87186 1 SUSC MIC 180.75
SUBTOTAL: 2234.50
310-PATHOLOGY LAB
121505 16B425 0732 088305 88305 4 SURG PATH LEVEL 4 2274.00
SUBTOTAL: 2274.00
324-CHEST X-RAY
122305 23Bl16 0721 255132 71010 1 XR CHEST 1 V 568.00
SUBTOTAL: 568.00
341-DIAGNOSTIC NUCLEAR MED
120905 09B682 0761 346044 78223 1 NM BILIARY DUCT W/WO R 2707.50
SUBTOTAL: 2707.50
343-DIAG RADIOPHARMACEUTICAL
120905 09B682 0761 346821 A9513 10 TC99M MEBROFENIN 1 MCI 220.00
SUBTOTAL: 220.00
350-CT SCAN
121605 16B434 0727 342024 74160 1 CT ABDOMEN W/CONT 1177.50
121605 16B434 0727 342051 72193 1 CT PELVIS W/CONTRAST 1201.50
121905 19B702 0727 342024 74160 1 CT ABDOMEN W/CONT 1177.50
121905 19B702 0727 342051 72193 1 CT PELVIS W/CONTRAST 1201.50
SUBTOTAL: 4758.00
351-HEAD SCAN
122205 22B040 0727 342020 70491 1 CT NECK W/CONTRAST 890.75
SUBTOTAL: 890.75
361-MINOR SURGERY
122105 21B902 0721 255512 1 PICC LINE PLACEMENT 3246.75
SUBTOTAL: 3246.75
390-BLOOD/STOR-PROC
121605 28J614 0758 042653 P9016 2 PRBC LR 302.00

EATIENT NO: 86604215 OCALA REGIONAL MED CTR BILLING DATE PAGE 16 00050
MED REC NO: 170343 P.O. BOX 406549 12/28/05
~ILLESPIE PENELOPE M 12/06/05 12/23/05

122205 23J562 0758 042653 P9016 1 PRBC LR 151.00

122205 28J604 0758 042653 P9016 1 PRBC LR 151.00
122205 28J605 0758 042653 P9016 1 PRBC LR 151.00
SUBTOTAL: 453.00
402-ULTRASOUND
120805 08B565 0730 348016 76705 1 US ABDOMEN LTD 929.25
122105 21B902 0721 255213 76942 1 USG NDL PLACEMENT 863.75
SUBTOTAL: 1793.00
420-PHYSICAL THERP
121005 10B780 0766 149517 97110 1 THER EXERCISES 15 MIN 38.00
121005 10B780 0766 149515 97116 1 GAIT TRAINING 15 MIN 76.25
121005 10B780 0766 149516 97139 1 UL THERAPEUTIC PROC 65.50
SUBTOTAL: 1574.00
424-PHY THERAPY EVAL/REEVAL
121005 10B780 0766 149521 97001 1 PT EVALUATION 215.50
SUBTOTAL: 215.50
483-ECHO CARDIOLOGY
120805 08B567 0751 184508 93312 1 TEE 2D W/WOM MODE COMP 2430.50
120805 08B513 0751 184508 93312 1 TEE 2D W/WOM MODE COMP 2430.50

MED REC NO: 170343 P.O. BOX 406549 12/28/05
6ILLESPIE PENELOPE M 12/06/05 12/23/05

SUBTOTAL: .00
610-MRI
121105 IlB841 0734 347016 74181 1 MRI ABDOMEN W/O CONT 2420.00
SUBTOTAL: 2420.00
730-EKG/ECG
120805 08B513 0744 093005 93005 1 EKG TRACING ONLY 332.50
SUBTOTAL: 332.50
750-GASTR-INTS SVS
121505 15B318 0735 183025 1 COLONOSCOPY 1804.25
121505 15B318 0735 183023 1 BIOPSY 310.00
121505 15B318 0735 183040 1 POLYPECTOMY 310.00
SUBTOTAL: 2424.25
TOTAL ANCILLARY CHARGES 62195.82
TOTAL CHARGES 74095.82

PAYMENTS .00
ADJUSTMENTS .00
BALANCE 74095.82

Page 1 of 1
Neil Gillespie
From: "Muldrow, W. Stephen (USAFLM)" <W.Stephen.Muldrow@usdoj.gov>

To: "Neil Gillespie" <neilgillespie@mfi.net>
Attach: ATT00005.txt
Subject: Read: Gillespie letter May-12-2017 to Stephen Muldrow USAFLM re Dr. Asad Qamar
Your message
To: Muldrow, W. Stephen (USAFLM)

Sent: Friday, May 12, 2017 2:00:04 PM (UTC-05:00) Eastern Time (US & Canada)
was read on Friday, May 12, 2017 2:32:56 PM (UTC-05:00) Eastern Time (US & Canada).
5/14/2017
Page 1 of 1
Neil Gillespie
From: "Philip, Celeste" <Celeste.Philip@flhealth.gov>

Your message
To: Philip, Celeste

5/14/2017
Page 1 of 1
Neil Gillespie

This is a receipt for the mail you sent to
"Stephen Muldrow" <w.stephen.muldrow@usdoj.gov> at 5/12/2017 2:00 PM
This receipt verifies that the message has been displayed on the recipient's computer at 5/12/2017 2:09
PM
5/14/2017
Page 1 of 1
Neil Gillespie
From: "Lambert, Alexis" <Alexis.Lambert@flhealth.gov>

Your message
To: Lambert, Alexis

5/14/2017
Page 1 of 1
Neil Gillespie
From: "zzzz Feedback, Health" <Health@flhealth.gov>

Your message
To: zzzz Feedback, Health

Sent: Friday, May 12, 2017 6:00:04 PM (UTC+00:00) Monrovia, Reykjavik
was read on Friday, May 12, 2017 6:12:39 PM (UTC+00:00) Monrovia, Reykjavik.
5/14/2017
http://www.justice.gov/opa/pr/government-intervenes-lawsuit-against-florida-cardiologist-alleging-unnecessary-peripheral
JUSTICE NEWS
Office of Public Affairs
FOR IMMEDIATE RELEASE Monday, January 5, 2015
Government Intervenes in Lawsuit Against Florida Cardiologist Alleging Unnecessary Peripheral Artery
Interventions and Payment of Kickbacks
The government has intervened in two lawsuits against a Florida cardiologist, Dr. Asad Qamar, and his physician
group, the Institute for Cardiovascular Excellence PLLC (ICE), alleging that Qamar and ICE billed Medicare for
medically unnecessary peripheral artery interventions and paid kickbacks to patients by waiving Medicare
copayments irrespective of financial hardship, the Justice Department announced today.
Performing medically unnecessary procedures puts patients at risk and contributes to the soaring costs of health
care, said Acting Assistant Attorney General Joyce R. Branda for the Justice Departments Civil Division.
Todays action evidences the Department of Justices efforts both to safeguard federal health care program
beneficiaries and to protect public funds.
The lawsuits allege that Qamar and ICE performed excessive and medically unnecessary peripheral artery
interventional services and affiliated procedures on Medicare patients. One of the lawsuits further alleges that
Qamar induced patients to undergo those unnecessary procedures by routinely waiving the 20 percent Medicare
copayment, regardless of the patients financial need.
Physicians should make medical decisions on the basis of their patients needs, said U.S. Attorney A. Lee
Bentley III for the Middle District of Florida. Performing medically unnecessary procedures solely to line a
physicians pockets strains our nations health care system, and can also jeopardize the health and safety of
patients. Fighting Medicare and other health care fraud is one of our offices most important priorities.
The lawsuits were filed under the qui tam, or whistleblower, provisions of the False Claims Act, which permit
private parties to sue on behalf of the government when they discover evidence that defendants have submitted
false claims for government funds and to receive a share of any recovery. The False Claims Act also permits the
government to intervene in such lawsuits, as it has done in these cases. The cases are captioned United States
ex rel. Doe v. Institute of Cardiovasular Excellence, PLLC, ICE Holdings, PLLC, Dr. Asad Qamar, & Dr. Humera
Qamar, Case No. 5:11-CV-406-OC-KRS (M.D. Fla.) and United States ex rel. Taylor & the State of Florida v.
Institute of Cardiovascular Excellence & Dr. Asad Qamar, Case No. 8:14-CV-1454-T-35-EAS (M.D. Fla.)
Physicians who try to enrich themselves and their practices by performing medically unnecessary, invasive
procedures can cause patients very serious health issues, waste millions in taxpayer dollars each year, and
undercut the publics trust in the medical profession, said Special Agent in Charge Derrick L. Jackson of the U.S.
Department of Health and Human Services-Office of Inspector General (HHS-OIG). We will continue to work with
our law enforcement partners to protect beneficiaries and hold health care providers accountable for such
outrageous fraud schemes.
This matter illustrates the governments emphasis on combating health care fraud and marks another achievement
for the Health Care Fraud Prevention and Enforcement Action Team (HEAT) initiative, which was announced in
May 2009 by the Attorney General and the Secretary of Health and Human Services. The partnership between
the two departments has focused efforts to reduce and prevent Medicare and Medicaid financial fraud through
http://www.justice.gov/opa/pr/government-intervenes-lawsuit-against-florida-cardiologist-alleging-unnecessary-peripheral
enhanced cooperation. One of the most powerful tools in this effort is the False Claims Act. Since January 2009,
the Justice Department has recovered a total of more than $23.3 billion through False Claims Act cases, with
more than $14.9 billion of that amount recovered in cases involving fraud against federal health care programs.
The investigation was conducted by HHS-OIG, the Civil Divisions Commercial Litigation Branch and the U.S.
Attorneys Office for the Middle District of Florida. The claims asserted by the government are allegations only
and there has been no determination of liability.
15-002 Civil Division

Updated January 5, 2015
Page 1 of 1
Neil Gillespie

To: "Lee Bentley USAFLM" <Lee.Bentley@usdoj.gov>; "FBI Tampa Division"
<tampa.division@ic.fbi.gov>; "FBI Jacksonville Division" <jacksonville@ic.fbi.gov>
Cc: "Neil Gillespie" <neilgillespie@mfi.net>
Sent: Tuesday, December 29, 2015 11:17 AM
Attach: 2007, 09-24-07, John H. Piccin Esq.pdf; 2007, 07-24-07, Ranier Munns, John Willis, Esq.pdf; 2007,
08-02-07, Robert W Bauer Esq.pdf; 2007, 08-22-07, Stephen J Knox Esq.pdf; 2007, 08-22-07, Victor
J. Musleh Jr Esq.pdf; 2007, 08-23-07, John Green Esq.pdf; 2007, 08-28-07, Scott R. McMillen
Esq.pdf; 2007, 08-30-07, Martin J. Goldberg Esq.pdf; 3 Amiodarone 200MG Tablets for PMG-
AsadQamarMD 2p.pdf; 1 DrAsad Qamar medical record for Penelope Gillespie-19p.pdf; 2 Rythmol
SR 225MG Capsules for PMG-DrA.Qamar 1p.pdf; medical cost, hospitalization and rehabilitation
$77,991.81.pdf; US Dept of Justice v Dr Asad Qamar.pdf
Subject: United States v Florida cardiologist Dr. Asad Qamar et al.
A. Lee Bentley, USAFLM
US Attorneys Office, Tampa Florida
Paul Wysopal, Special Agent in Charge

FBI Tampa Division
Michelle S. Klimt, Special Agent in Charge

FBI Jacksonville Division
RE: United States v Florida cardiologist Dr. Asad Qamar et al.
My mother Penelope M. Gillespie was a patient of Florida cardiologist Dr. Asad Qamar in 2005-2006.
Attached you find Dr. Asads medical records for Ms. Gillespie, and prescriptions written by Dr. Asad
for Ms. Gillespie.
Also attached is my written communication with eight (8) attorneys who reviewed what I believe was
medical malpractice by Dr. Asad, his planned cardioversion for Ms. Gillespie for chronic atrial
fibrillation. I stopped the cardioversion, which likely would have killed my mother. Ms. Gillespies
adverse reaction to the drug Rythmol SR 225 MG left her hospitalized and near death. The cost of Ms.
Gillespies hospitalization and rehabilitation was at least $77,991.81. Medicare and private insurance
covered most, if not all of the cost. Thank you.
Sincerely,
Neil J. Gillespie
8092 SW 115th Loop
Tel. 352-854-7807
5/14/2017

medical costs, recent illness

West Marion Community Hospital, Dec-06-05 to Dec-23-05 (a.k.a. Ocala Regional MC)
Timber Ridge Nursing and Rehabilitative Center
amount:
$74,095.82 hospital bill, West Marion

2,169.00 doctor bill, 7 Hill Gastroenterology
277.00 misc. doctor bills
736.45 Ocala hospitalist group
78.64 misc. doctor bill
$77,991.81
CENTRAL FLORIDA
HEART CENTER
MaIoCemwu
3JI0S.'lf. 34th Street
Ocala. Florida 34474
Telephone: (352) 873-0707

CONFIDENTIAL
Fax: (3S2) 873 ..9615
joIeph R. Alonso, M.D., FACC AUTHORIZATION FOR RELEASE OF MEDICAL INFORMATION

WiIltam Ii Dresen, M.D., FACC
Siva S. Oummadi, M.D., FACC
Vljay K. Mittal. M.D., FACC Name of Patient: f}N ( L pe
t! /1. (;, lie ~'p1 .e
Jay Pmcha1, M.D.
Asad U. Qamar, M.D., FAce, FSC&I
Swamop Rat. M.D., FACC
Date of Birth: af-d. 4 /930 SS# I e6 - c':l q- CJo3s
~CLV"
1raM. Stone, M.D., FACC
Fredrick M. Yutanit M.D. I HEREBY AUTHORIZE:'1::){.
South Cemmy:
(Use Stamp)
10435 S.E. 170th Place
Summerfield, Florida 34491
Telephone: (352) 347-7923 TO RELEASE INFORMATION IN MY MEDICAL RECORDS INCLUDING (UNLESS
Fax: (352) 347-6187 NOTED):
Information about communicable diseases and infections as defined by
JUIdD Ferns, M.D., FACC

statute and Florida Department of Public health rules (which include
Sift S. Gummadi, M.D., FACC
Ali NUIeIi M.D., FAa:

venereal disease "VD", tuberculosis, "TB", hepatitis B, human
ANI A. Shahmiri, M.D.

immunodeficiency virus "HIV" acquired immunodeficiency syndrome
Julio c. Uprte. M.D.

"AIDS", and AIDS related complex "~RC").
Alcohol and drug abuse treatment information protected under the
PvkPoIot:
regUlations in 42 code of Federal Regulations, Part 2.
Jf S.~ 34th Circle Mental health treatment records, psychological services and social
Suite 101 services information communications made by me to a" social worker or
Ocala, Florida 344 74 psychologist.
Telephone: (352) 347-2315

Fax: (352) 8S....s192
I AUTHORIZE SUCH DISCLOSURE TO THE INDIVIDUALS OR ORGANIZATIONS
. .Ferns. M.D., FACC LISTED BELOW IN ACCORDANCE WITH THE CONDITIONS LISTED ABOVE .
\Ii Nalleli N.D.. FACC
Persons(s) or Organization(s) to whom disclosure Is to be made:
........m family Ucdlgph
:150S.~ IiwJ ZOO. SuIte 100
Ne l , G,J/r'Ye.
bIa. FlorIda J+f81
eIepbane: (352) 873..1010
ax: (352) 873-4387 (u~estamp)
rIDiftIa Murthy. M.D. This authorization is subject to written revocation at any time, except to the
extent that action has already be~n taken in reliance, on the authorization. If not
IepIwrIUdr previously revoked, this authorization will terminate six (6) months from the date
101 S.~ H~ ZOO of this signature.
Cl.~)MLL(F
.. 700, Salle 703
ella, FlorIda 34481 SIGNATURE OF PATIENT:j DATE: _
Iephoae: (352) 873..7600
x: (352) 873-6941
SIGNATURE OF WITNESS: DATE: _
'NTRAL FLORIDA HEART CENTER. L
th
3310 SW 34 Street
352-873-0707
GILLESPIE, PENELOPE
Patient MRN: 12134
DOB: 10/29/30
Date of Service: 1/25/2006
Asad U. Qamar, M.D., FCCP, FSGC, FACC, FACP, FSC&I
TRANSESOPHAGEAL ECHOCARDIOGRAPHIC STUDY
INDICATION FOR STUDY:

1. Preparation for cardioversion, atrial fibrillation.
PROCEDURE: Informed consent was obtained. The patient was placed in the left lateral
position. Benzocaine spray was used to anesthetize the oropharynx. Intravenous Versed and
intravenous fentanyl were used for sedation. Continuous cardiac and oximetry monitoring was
available. Also, oropharyngeal suction was available. A mouth guard was placed. An HP 5500
OmniPlane probe was passed without any significant difficulty.
RESULTS:
1. Mild dilatation of the left ventricular cavity, left ventricular ejection fraction 50 percent.
There is mild concentric left ventricular hypertrophy. The papillary muscles are normally
situated. No intramural thrombi in the left ventricular cavity.
2. Moderate dilatation of the left atrium with four normally pulmonic veins. Absence of any
spontaneous contrast or thrombi in the left atrial body or left atrial appendage.
3. Moderate dilatation of the right atrium with normally situated superior vena cava, inferior
vena cava and coronary sinus.
4. Intact intraatrial septum.
5. Intact interventricular septum.
6. Normal pericardial signal.
7. No pericardial effusion.
8. Trileaflet aortic valve without aortic stenosis or aortic regurgitation.
9. Color Doppler examination indicates the presence of moderate mitral regurgitation.
10. There is mild tricuspid regurgitation.
11. There is no pulmonic regurgitation.
12. The proximal main pulmonary artery is normal in size.
13. The aortic root is normal in size.
14. The descending thoracic aorta exhibits diffuse, mild atherosclerotic plaque.
CONCLUSIONS:
1. Normal left ventricular systolic function.
2. Moderate mitral regurgitation.
3. Moderate dilatation of the left atrium.
4. Moderate dilatation of the right atrium.
5. No significant spontaneous contrast in the left atrial body and left atrial appendage.
6. No intramural thrombi. ,
COMMENTS: A plan for c a r d i o v e r S i : Z d e o , .
(
~
I
J?p
AUQ pce
V: 335639 D: 04/12/2006 T: 04/13/2006 14:31:45
.OFFle ) 1- ,,~
n=N==A=M=E=:;:::::=F==E=~::;::::r===~
=,-=r_~:~~=_:;=:;::._=I2=UU::=_,,_=-=__=~_=~_===
__=~_=_=_~.'~~'~~ 1=W-?::18=TA=::=:::;~1 ===~~~==:TE:=HO=-:F~=__=_=N="~"_=~ ======1 Formedie =Ie
ADDRESS PHONE (H) (0)
1~----~~------"'----------------------------------1I~
OCCUPATION / REFERRED BY $
E;M~_~QY.~........................ . . ." _ _".. . . . . . " _ _ "." 11 ::x:
MEDICATIONS INSURANCE =
DATE I
DIAGNOSIS
CPT CODE
I HT
L:2~~Q~_I . ,. . t ..=.. ,, , ~
....................j .
t .
I
~------
.1--_..__ N.-t_. N N . NN.
.~~.-+-----_._------_.__._---- ~~~~~~~~~--IT-~I
!
.
.t--..-~-----__-t- ,,-__,,-___-___------------~-L-J:.L.\-~~~.uJJJ.~~L.l.<~
..--,,__ ~ I
ASAD U. QAMAR, M.D. , FCCP, FSGC, FACC
Central Florida Heart Center
th
3310 SW 34 Street
Ocala FL 34474
Phone 352-854-0681
Fax 352-854-8031
PROGRESS NOTE
Patient Name: GILLESPIE, PENELOPE

Account Number: 12134
Asad U. Oamar, M.D., FCCP, FSGC, FACC, FACP, FSC&I
REFERRING PHYSICIAN: Dr. Donald Liebelt
~~.
I had the pleasure of meeting Ms. Gillespie in follow-up today. As you know, Ms. Gillespie
is a pleasant, 75-year-old, Caucasian female with the following medical issues:
1. Chronic atrial fibrillation currently on Coumadin and Rythmol therapies.

2. Chest pain.
3. Systemic and pulmonary hypertension.
4. Mitral regurgitation.
5. History of transient ischemic attack in the past.
6. Skin cancer.
7. Status post bilateral total knee arthroplasties in the past.
8. Chronic fatigue.
9. Palpitations.
10. Coronary artery disease.
11. Hypertensive heart disease.
12. Peripheral vascular disease.
13. Angina pectoris.
REVIEW OF MEDI,CAL RECORDS:

1. A 24-hour Holter monitor on 11/17/05 revealed atrial fibrillation with frequent pauses
and one pause measuring up to 2.1 seconds and another pause measuring 2.2
seconds. The patient demonstrated a heartbeat of 51 beats per minute at 10:25 p.m.
On a few occasions, the patient did complain of lightheadedness and dizziness.
PHYSICAL EXAMINATION:
BLOOD PRESSURE: 128/83 mrnHg; PULSE: 74 beats per minute and irregular.
WEIGHT: 193 pounds.
The lung fields were clear bilaterally. Soft bilateral carotid bruits were appreciated.
There was no thyromegaly. Jugular venous pressure was normal. The radial pulses were
equal and palpable and irregular. S1, S2 heart sounds were normal. A murmur of mitral
regurgitation was appreciated. The distal lower extremity pulses were palpable. There was
no significant pedal edema noted.
PLAN:
1. The patient still remains in atrial fibrillation. We will plan electrical cardioversion in
approximately two weeks.
2. We will obtain a repeat 12-lead electroc~dioQra..."1toda1.
3. Continue metoprolol to 25 mg p.o. b.i.d.f1'~P\.6t)c./'"
4. Continue Rythmol SR 225 mg p.o. b.i.d.'Dl L-
Page 1
"' )
PROGRESS NOTE

5. Continue Coumadin 5 mg alternating with 2.5 mg every other day.~ U

6. Continue DynaCirc CR 5 mg q.d. vl<!../
7. Continue Lasix 20 mg q.o.d. \)lc,
8. Continue KCI 10 mEq p.o. q.o.d. ~lt"" ~
9. Continue prazosin hydrochloride 2 mg p.o. ~i.~d. J{ (!..,,,
10. Continue Diovan HCTZ 160/12.5 mg p.o. q.a~ __ .-.-.----.r.
11. Continue Diovan 160 mg p.o. q.h.s.~
12. Continue prednisone 10 mg p.o. q.d.!itt!.-'
13. Continue Namenda 10 mg b.Ld. ~
14. Continue Aricept 5 mg p.o. q.a.m. t>\ e/
15. Aspirin has been discontinued.
Thank you for entrusting me with Ms. Gillespie's care.
Dictated by Lisa Wills, R.N. for Asad Qamar, M.D.
Very truly yours,
AUQ:kbg
D: 12/07/2005
T: 01/24/2006 09:58:20
VID: 316609 TID: 309146
cc: Dr. Donald Liebelt
Page 2 of 2
')
)
ASAD U. QAMAR, M.D. , FCCP, FSGC, FACC
Central Florida Heart Center
th
3310 SW 34 Street
Ocala FL 34474
Phone 352-854-0681
Fax 352-854-8031
INITIAL CARDIOLOGY VISIT

Asad U. Qamar, M.D., FCCP, F5GC, FACC, FACP, F5C&1
REFERRING PHYSICIAN: Dr. Donald Liebelt
Dear Dr. Liebelt:
I had the pleasure of meeting Ms. Gillespie in consultation today. As you know, Ms.
Gillespie is a pleasant, 75-year-old, Caucasian female with the following medical issues:
1. Chest pain.
2. Intermittent lower extremity edema.
3. Fatigue.
4. Palpitations.
5. Headaches.
6. Visual disturbances.
7. Systemic hypertension.
8. A family history of heart disease.
9. History of transient ischemic attack in the past.
10. NO HISTORY OF MEDICATION ALLERGIES. False; allergy to Methotrexate
11. Skin cancer.
12. Status post cardiac catheterization in the past.
13. Status post bilateral total knee arthroplasties in the past.
REVIEW OF MEDICAL RECORDS:

1. Recent bloodwork on 9/27/05 revealed triglycerides 152, total cholesterol 186, HDL
57, LDL 99, random fasting glucose of 81, BUN 26, creatinine 1.1, sodium 142,
potassium 3.8, liver function test within normal limits. CBC within normal limits.
T5H within normal limits.
2. A 24-hour Holter monitor on 11/17/05 revealed atrial fibrillation with frequent pauses
and one pause measuring up to 2.1 seconds and another pause measuring 2.2
seconds. The patient demonstrated a heartbeat of 51 beats per minute at 10:25 p.m.
3. A 12-lead electrocardiogram on 11/15/05 revealed atrial fibrillation with a QRS
duration of 76 milliseconds with nonspecific 5T-T-wave changes.
4. Cardiac catheterization by me on 9/9/05 revealed an left ventricular ejection fraction
of 55 percent, with pulmonary artery systolic pressure of 40 mmHg, 2+ mitral
regurgitation. No evidence of aortic stenosis or aortic regurgitation or mitral
stenosis. Mild concentric left ventricular hypertrophy, diastolic dysfunction of the
left ventricle, 20 percent stenosis in the mid segment of the left anterior descending,
no angiographic disease in the left circumflex or right coronary artery.
PHYSICAL EXAMINATION:
BLOOD PRESSURE: 124/72 mmHg; PULSE: 84 beats per minute and regular. WEIGHT:
187 pounds.
1he lung 'fields were clear bilaterally. Soft bilateral carotid bruits were appreciated.
1here was no thyromegaly. Jugular venous pressure was normal. The radial pulses were
~qual and palpable and regular. 51, 52 heart sounds were normal. No significant murmur
Page 1
PROGRESS NOTE
was appreciated. The distal lower extremity pulses were decreased but palpable. There
was no significant pedal edema noted.
PLAN:
1. We will decrease metoprolol to 25 mg p.o. b.Ld.
2. Add Rythmol SR 225 mg p.o. b.Ld.
3. We will check his repeat PT/INR on Friday.
4. We will schedule patient for 24-hour Holter monitor.
5. We will check a transthoracic echocardiogram.
6. The patient will be seen in follow-up in two weeks, at which time a 12-lead
electrocardiogram will be performed to follow-up on patient's atrial fibrillation.
7. Continue Coumadin 5 mg alternating with 2.5 mg every other day.
8. Continue DynaCirc CR 5 mg q.d.
9. Continue Lasix 20 mg p.o. q.o.d.
10. Continue KCI 10 mEq p.o. q.o.d.
11. Continue prazosin hydrochloride 2 mg p.o. b.Ld.
12. Continue Diovan HCTZ 160/12.5 mg p.o. q.a.m.
13. Continue Diovan 160 mg p.o. q.h.s.
14. Continue prednisone 10 mg one half tablet q.o.d. as per your recommendation.
15. Continue Namenda 10 mg b.Ld.
16. Continue Aricept 5 mg q.a.m.
17. Continue aspirin 81 milligrams, enteric-coated, p.o.q.d.
Thank you for entrusting me with Ms. Gillespie's care.
Dictated by Lisa Wills, R.N. for Asad Qamar, M.D.
Very truly yours,
AUQ:kbg
D: 12/07/2005
T: 01/24/2006 09:46:47
VID: 316605 TID: 309145
cc: Dr. Donald Liebelt
Page 2 of 2
CILLSPl. PENELOPE t1 ID: 000012134 CENTRAL FLOR IDA HEART CEt.I J Lou ~
24-JAN-2006 ~8
I?>~
. J_
25mm/s Ned:
lOmm/mV 75yr Ht: Wt: ATRIAL FIBRILLATION WITH SLOW VENTRICULAR RESPONSE
100Hz Sex: F Race: NONSPECIFIC ST ABNORMALITY, PROBABLY DIGITALIS EFFECT
Pgm 007B Loc: Room: ABNORMAL QRS-T ANGLE, CONSIDER PRIMARY T WAVE ABNORMALITY
v206 I"*"' ABNORMAL ECG
Vent. rate 54 BPM
PR interval
QRS duration 84
ms
ms .cI \ 1/\ r-
Cart: 0 aT/aTe 424/395 ms
Tech.: ~ P-R-T axes 62 -14
I:
II
I
n: v, ,
III
'~
AU- 'tJ'tJUU&'-I...I' \oiL. .va:;."" LUU;J-;-;r ~CNIRftL rLU~JUfl M~RKI ~~Nl~K
25mm/s Ned:
IOmm/mV 75yr Ht: Wt: ATRIAL FIBRILLATION
100Hz Sex: F Race: SEPTAL INPARCT. AGE UNDETERMINED
Pgm 007B Lac: Room: ABNORMAL EeG
v206
\
I Vent. rate 60 BPM
I
I
J
PR interval ms
' -....-~ QRS duration 80 ms
Cart.. a QT/aTc 408/408 ms
Tech. : l1.M- P-R-T axes 61 59
L
Referred b~: QAMAR Unconfirmed
I T-f-ijtlif-~ffat+liat~ y Ii~, t]-' _.FE
It .~~r- _ .~. . - t~f-i ~::: -'", 1 t+f-t~ '1::4*' ~~~tt "
~Io.
./ i
- . - 'j.Rff- =FFFf . -t~ti =,,:, .- tt i+ H . -~, W:ltt-it ":n

;t'ff ~;Ufl:rj:jLtr>I:1: f~
f ; ~
- .
+ ~ ": ., , ' . : . ttl
.
~.
.[.tl-,r
t~tl<L
_l'
J.1l1~t
. ~I i.~
-t++ttlL " r~~t-8f.~l 1. I~ ' ~;"
.
I :+ Il-.
-+ I i+} '-, "," i',ll"," T +F,l,
-~~t(I.lt!, ,__ :T .~.l.
. ..
.
,. '
. ..1 ' .
(
~ 1
~~.,-
IF '..~+r '-i~lt-.
1- .f.-
1 ri.!itit .
--Tl'Jill=UW' -' . .. ,':-1-I-' '~I'"tH
", "
-
1~.n,:J']EI
.. ~ilttt.=~Il~
-'..j f-
Wa__lH++++H+J+HH~r~)llll
:, -IT .. _, .~~ I '. +++H++. ': ,~t:~..Il_U . ,_I
flit ~tHi f
,,',8' '.
:: - '.:'1.
:lJ11 II, T,~ ..
j:.j:Ltt ~ +h
,', " ,
-,
'
.I
,:1ff~EffIlJltc!+c
" .. "" k.LL1.J...j+t
I Ll..LLLLLJ
- ,J '.1"
'_ '~'~"";i_.~+, .. , ._t. "
1f!tl
f-I--l-lP-p r::rP-T'-;--!
.H'lt
,~lltlj - ,if
' '... Ffll~liL
.
f-:H n::r:m1-1-=q::n::n-~T!l-t~:rrn
n~.q p:qT-f-r-~ ~.
I.d!.
n::ri~-
I
" i-i '1-+-I-i'i+fdf1~.1~ff11tBtl::!i!-I::Lt~t~ttJ-tt!

1::"-'
.Jt, tte~
~,:_ ft~rtrmoomtmtffff~]OOm1M~i#~~~mr8tWffi
~'~~~'~_'III'~~~~~~~~~~~~~~~~~~~~~~ .~_1-;,1,.'lmwmmt1lfnfulWffit~I+f1-Dlffi+H~rttmt~::+-m~H~Jj-J~
I
J
~~!fI4~Hl~~~
-r..
... -"-.J....I " ,.,.,.t-l-H,...' .......- t ..
, . , h.,., .. II'
H~
I : I I , I I I I I 'I ! I I 1 I ~ I I;; I :! iii I ! I ! I ! I I I : I I I I I I 1 j Ii; I i
.::!! IILlHUJ:iYi-IlfiIWlqnl:1
~-: 1.
HII: Iii;: l!jHiTi I]!
f+~
iIlrl I i ii iii'
'~l:l 'it.d_1.Ill:~J~JJ~.~t~J.l1i::LiL!~'hV-'4-\' _i~__ ~ I U_~IJ.~ . Lt.'
I
1'1rtiI'I:IJij~Inlrufl:i:ili~jiiii!illl'll!il~J[
L1
i.! 1 _ ',-i J,
J ilU c , -m WtH ::.. ~H' jiJll'iJili L! i1li B:I'iidi

;j i I{i tiT"!
: .
'J-i'~'J+ I
. t ~J. ~ Irffl~ J --1
Ic iJ'~ i r,~, 't. r ..~}{' ~ ..
I" ii, if'
E.lt .[ 1"'h'-,+' I
< i
,~~ I'r'~n ,J-LIJ~1t'" 1;id ( :,i ~:Jc'l
..i 1.lt . =11
~
j. xi", '1 I-t :n~--I!
~_... 1" J .
1 'i fI , ,I!, I I I J .. , l l/ I I
.w.. l:::Ll ' , __ llJ-1,

i J - 1_
j-+i ,I !' I,,!,', , ,-I;: H-Lw1J_, r
f (: !
,1, - : H--; l+! .j
. .,
"1---=-.ttF_, Ir::,+J.rm'
.~Ttl{ttj~
I-t
" J} 1+ 3J..:
.~::r:ll::nJ.1..ttLttjjJjj1Jj~t'lj-tHij-i
t l-tll'H-i r-H'H1\:H.!.I+l _..=t
::ffittti-nJ ~+-l-!-f- + -'- +'+-I-\-t-II ~~:- l-t--'l,-~"~~'I~-~JI.=JtB"::".,-I':
., '-_.' ''.''-'~,:,~mD!ffi1ii '~~'--'~:-e' WI, .ijLil'',1.-I-I.".,,~
::'bi'~T=1::r-=+i.o
ITUL_
~lii - '" --I -+.. ~," .. ~~-rJ:['-r::+=l+.'::jJ_8i:-
~ li[.l.,'-r ,',t. . ', -," . - -.. '.." , . ", ':'t.,
L - '
Iff:: Wi :~ 11+1--rl:~:,Ji:
'-, t
W: h(ff,',i.. ~J ~ ~~ .~~: I
__ .. 'i-1
."~.j, . . . . ~ : E' 1+ J-
"~IFHi+
I , ,- - ,-
'I~-~-
'..
-R+1=m::r-n+-I1=i-nrt++lrn+1lt-1~~lR=RHFFFH-IffB-1RfTH t 11=1
ir:t'].,.'.'''LLLU l:t - , + . .
--t-fF-H-1=+lf.l=t:+++=t+ltrl-1J-T+f4l-httlJ:l::H+,:H1:1 H-I H+I+H+I \ H-I
I 1-8805
MADE IN USA
12/02/2005 13:52 3522379876 CFHC PAGE 01
1
1
CENTRAL FLORIDA HEART CENTER, P ~A.
3310 S. W. 34~h Street
Ocala, FL 34474
(352) 873-0707
HOLTER MONITOR
Patient Name: GILLESPIE, PENELOPE Age: 74 Sex: F
Account Number: 12134 D.0.8: 10/29/30
Date of Test: 11/17/05
Asad U. Qamar~ M.D., FCCP, FSGC, FACe. FACP, FSC&I
INDICATIONS:
1, Atrial fibrillation.
MEDICATIONS: Coumadin, DynaCirc, Lasix, potassium, metoprolol t Prazosin t Diovan,

Rythmol, Namenda, Aricept, NitroQuick.
RESULTS:
1. A 24 hour Holter monitoring was performed.
2. The lowest heart rate recorded was~ats per minute. The highest heart rate
recorded was~ beats per minute.
3. The predominanTrnythrn was atrial fibrillation.

4. There was presence of conduction system disease.
5. Frequent pauses were noted. One pause measured...2 1 ie{;Of1ds. Another pause
measured... 2.2 seconds.
6. The patient demonstrated a heart beat Of~ts per minute at 10:25 p.m.
Clinical correlation of above is recommended.
7. On a few occasions, patjent comprained of Jightheadedness and dizziness. Again
Clinical correlation is recommended.
8. Patient may require implantation of e pacemaker.
Asad U. Qamar, M.D., FCCP, FSGC, FACe. FACP, FSC&l
AUQ: kbg
D: 11/25/2005
T: 11/29/2005 08:54:09
314618/301748
Page 1
u!~~C~rIC. rCACLurc 1U UUUU 1 '- 1 ~4f ( 1 ~-NU v- ~U~ +++"'f'tS C~NJMAL PLORIDA HEART CENTER
~ I<-f~
Z5mm/s Med:
10mm/mV 75yr Ht: Wt: ATRIAL FIBRILLATION
100Hz Sex: F Race: LOW VOLTAGE QRS
Pgm 007B Lee: Room: NONSPECIFIC T WAVE ABNORMALITY, PROBABLY DIGITALIS EFFECT
v206 /.. .:~'"~, ABNORMAL ECG
I
I
Vent. rate 61 BPM
I PR interval ms
t
.....""1 QRS duration 76 ms
Cart: 0 QT/QTc 408/408 ms
Tech. :/-t.. P-R-T axes 42 22
Referred b QAMAR Unconfirmed J
-r
-"::f-l-!-i++-'I+H~++++H--H
--l='ttL~'
'~mf f
"~r
t'rt-~~
m
-~"rlTn'~'I""'I"'I-H+'H
. ~r-_.,_ f
1
:+ '.11
m t!ittlti:::l+tttl+~f+~I:::I~ml = -- I _ Lr
-l.~--
.;ti-
'r~ l=t~1:1=ilRI~ n=rttrnltt ~L.,..
r' . .
R= '
x,:.
t-t-+'Hjj-, ,It-, . "::1
-~~II-r-UJ=~mi=rw::\.+.~t+n ~~ ; _ T - j::,'.H-I-f++H+H+I-H
~rtf-"t:
.u4: jnJillE~urr~-tr.n~mtiE::tttJta~tt~
rtm~mttll+lt1
1=mtT
Ff f','::
. r :t_. l~
"_~ f
+ . ...::.~+++H+H+H--H-H-H-f'+1
H:_ ,.. -r-r-!,.I-l-!-j
t r: ::~~[''-'- . - - '-j:
,.,r
.
~.I-ll-i-+.~.i-i-j'::I::l-'l:: . '. .~#..L.
i
H-t,
'~--j-+
'_dj= '\:'
.,. ~.-~ft:: ~ .. lw i
J
1= rcrtttt::
-t_
1" ... -.~ ...

-ttt~
.,.C- 1
tm
,I
H"'I-H+H"H-H-~tmlmE6~tn-tl1tt ,tt :TEEffHfFITEH-H+1~-
FT "1"1
" _ .'+H t+ti+l
-ni.-itttlrttttttll-W..w.++-I-1--1-1- -tt-t"1:ffi.;=.JffitU-1-++H-1-1 H++H-H+
::t'+:i=1 W -.- FtttH--H-++-I~++-l-H-l:rl ..ti
_. ' ~ ~~= ~ '.~ . ~ . ffili
,
_ .1II1-I-t-4+-I.I-I-I.+I.-I-lj
.. ,-~~ _. .,'I1'i-, ~ ' .... _t f~~'lF' .1-1 4I~-
!1:'.it~lIl;fffya~;tItW~fJJf:~trtitIJlf:j~:':lr~f:~~r$frIW11f!~1W-Jrffl~'tl-.f' . ~f~tlR~tr$flJmtfrmrfatRfP.i"
~~. :~~ +:
:trt=n::p=.r::
ttttl:!+
OO.'-lttTf:r!:t: ti j:Hht 1.1 nH i: +In tf HI-} .' ~]1.r fffn~T 10:lliAAhf1

._ "1+-1 flllt . _ Efti~it.ffifftffi. ~. ,: .=~1TR-t~.H-I-I.H"H+H
. + f " , ..1
l' .'.'4~ffitr~nlntftttjnWJttflmittlJWmtt-ltHt~lj~lfJ-{ifIJW'~mFf~WmW-i-Kl~rri': :_+ I +'~ IJfiHltml'nr .J1il-m+cWill-I+;~+tlmH+H -I' : . r
-' ~. ~ft.~i _rTt:l t rJf: {~1fW=1+~t-tf.t . ~T~!li.tJ~l~It1J,~t 'I:r~~ +tI- l"-rll+13.'1]t}j=t Jl.. d.-l.-.. 'f~:I~n-I . '-!!l-j. -.= ...~... + 1 - : l . - .,l+H- J+ .H+ Il1lrH+-+ftfHitt.. "l[H-+tH+H-H+H~I~~i+
Effi..IE.~.ffir_mf1_mEf~.::n:~m~~~*ktft~f1m-~fiH:,~$*f-lit:~rUnl1\FiiF;i.i~r+l-,41ii:~:rm+fH :. '~'l~umffijlttnffTh11i-~~~J1-'tJ~-+,~;.: . .
I-I-l- ffr~~l~_~-r~l~irJi!CF \~-4 . ,-clt,rUr. ' r .... :- .,
-I-I-+~.-II-I-++-I-H-j+i'-
MADE IN USA
111111111111111111111111111111111
10/11/2005 15:42 FAX 352 732 6934
Munroe R8sional 10/3/2005 1:27 PAGE 0141015 Fax server
n
)92/4.11
..
,s. ..._
1M
64 .,
I' ..
~;a,.wDErraIDWARDS
,'.. 'a-iaV lOOlla MD U&:a om: 1 JDM. . .1rzd1Dri 01U8:

",1.,1
:.. '
"
,..
I
!
732 6934 raJ 022
Munroe Relional 10/3/2008 1:27 PAGE 015/015 Fax server

.- ',I Jllll.JIIDd,.aIU
:1.
'0: 70 UN
,:tl e:.-.Ia ..
..~!'~4 JIMa
10
..
:.~.: 12 ...
.. ,~
~~
;l~
.
,
TnWchma usrmm'WARDI
) ..'
.'~
J'
.
~
.'.
:=J
.:J.
.~'
!
I'
.~
Ial 006
CENTRAL FLORIDA HEART CENTER, P.A.

CARDIAC CATHETERIZATION LABORATORY
CATHETERIZATION REPORT
P.tlent N.m8: GILLaSPIE, PENELOPE Date of birth: 10128/3Q
D.le of aervlc.: 919/05
Aooount Number: 12134
Asad U. Olmer, M.D., FCCP. FSGe , FACe. FACP. Fsoa,
PROCEDURES:
1. RIGHl AND LEFT HeART CATHETERIZATION.
2. CORONARY ANGIOGRAPHY.
3. LEFT VENTRICULOGRAPHY.
4. AORTIC ROOT, AORTIC ARCH AND DESCENDING THORACIC AORTOGRAPHY.
I. ABDOMINAL AORTOGRAPHY.
8, SELECTIVE BILATERAL RENAL ANGIOGRAPHY.
7. SELECTIVE BILATERAL ILIAC AND SELECTive BILATERAL FEMORAL
ANGIOGRAPHY.
BRIEF HISTORY AND INDICATIONS FOR PROCEDURE:

1. Mltrar regurgitation.
2. Angina pectoris.
3. Coronary artery disease.
4. pulmonary hypertension.
5. Systemic hypertension.
6. Hypertensive heart disease.
7. Peripheral vascular dlsesle.
8. Atrial fIbrillation.
PROCEDURE
VASCULAR ACCesS: Vascul.r access was gelned via the right common femoral artery
an(J the tight common femoral vein. A 8Frenct't .hart arterial .heath we. used. No
difficulty wa. encountered In gaining vascular access.
CATHETERS USED SUCCESSFULLY:

1. 8~Fr.nch JL3.,5
2. I-French JR3.S
3. .-F.-.nch 8ngulat.d pigtail calhater.
4. ".5 French Baxter balloon flotation thlrmodllutlon SWln-Oanz catheter.
DYE USED: Optlray was used.
v
. SEDATION: Intrevenous Vet.ad and Intr.venoul fentanyl cltrato w uaed far aedatlon.
CLOSURE DEVICE: A V.loSlar femora' Clolure deVice was uaed.
RIGHT HEART CATHI!TI!RIZATION~ The pulmonary artery systolic pre.sufe 40 mmHg.

The right Itrl81 meln pressure 10 mmHg. No Inlr.cardlac shunt. were noted.
LEFT HEART CATHETERIZATION: The left ventricular ejection fraction was 55 P.rce~t.
The lefl ventricular end-dla.tollc pr."ure W81 18 mmHg with early dltolic pressure of 4
mmHg. Norm.1 I.ft ventricular c.vit~ size with mUd concentric left ventricular hypertrophy
and 2+ mitral regurgJtltlon and dleatone dy.funclfon. The aortic root we. normal. The
aortic valve appeared to have three lelfletl. ..
Chart Copy
Pege 1
141 007
Patl.nt Nlme: GILLESPIE, PENELOPE Date Of .ervIC8: 8/8/06
AOGount Number: 12134
No gradient was recorded 8crO.8 the .ortic velve or aerO.8 the left ventricular outflow tract
on pullblCk of the pigtail catheter from the left ventricular cavity Into the proximal Bortle
root.
AORTIC ROOT, AORTIC ARCH ANGIOGRAPHY AtiD DESCENDING THORACIC
AORTOGRAPHY: The eorUc rootcendlng aorta.. aortic ere" .nd descending thoracic
aorta were normal.. There was no aortic regurgitation.
CORONARY ANGIOGRAPHY: The left main coronary arlery was free of anglogr.phlc
disease. It bifurcated into left Interior descending end left circumflex syslem.
Tha laft .nterlor de8cending exhibited I 20 percent stenosis in the mid-segment.

I The reft c;lrcumflex was free of anglographlc dl
The right coronary artery was anatomically dominant veslel. No anglogtaphJc dlseale was
noted In the right coron~ry artery.
ABDOMINAL AORTOGRAPHY: The .tudy II done because of 8 cliniC diagnosl8 of
perlpher81 vascular dl The suprarenal abdom'na' aorta W88 normal. The Infr.rena'
abdomln.' aorta was normal.
SELECTIVE BILATERAL RENAL ANGIOGRAPHY: Selective rIght renal angiography
demonstrated englographlcally normal right renal artery.
Selective left renal angiography demon,tr.ted anglographlcally normal left renal 8rtery.
SELECTIVE BILATERAL ILIAC AND FEMORAL ANGIOGRAPHY: SELECT'VI

BILATERAL ILIAC AND FEMORAL ANQIOQRAPHY~ The right common Iliac artery was
selectively cannUlated. T'he rIght common iliac artery. right external lilac artery, right
Internal Iliac artety. r;ght common femoral artery. right superficial femoral artery and right
profunda 'emoria were patent.
The 111ft common Iliac artery we. selectively cannUlated. The left common Iliac artery, left
Intetnailliac artery, left Ixternalillac artery, I.ft common '.mora' artery. 'eft 8uperflclal
'emoral artery and left profunda ;emorls were patent.
CONCLUSIONS AND Re:COM"ENDATION8~

1. Left ventricular ejection fraction 55 percent.
2. Left ventricular end-diastolic pre.lure 18 mm Hg. early diastolic pressute of 4 mm
Hg.
3. Normal left ventrlcula, cavity Ilze.
4. MUd cDncentrlc left ventricular hypertrophy. .
5. Pulmonary artery systolic pressure 40 mmHg_
6. Right afrial mean pressure 10 mmHg.
7. No Intrecardlac shunts.
8. 2+ mitral regurgitation.
9. No evidence of mitral stenasla.
10. No .vielence of aortic regurgitation.
11. No evidence of aortic stenosis.
12. No evidence of Idiopathic hypertrophic Bubaorllc ttenoeis.
Chart Copy
Page 2 of 3
raJ 008
Patient Name: GILLESPIE. PENELOPE Date of ServIce: 0/9/05
AOGount Number: 12134
13. Normal lorUc root end normal Barile arch with normal descending thoracic 80rt8.
14. OJ_stolle dysfunction of the 'eft ventricle.
16. 20 percent stenosas of Ihe mid-.egment of the left anteriOl descendino..
18. No anglagrsphic dis.... of the left circumflex.
17. No ancuogfaphic dl.lase of the right coronary Brtery.
18. Normal supra and Intrarenal abdominal aorta.
19. Patent bilateral renar veell.
20. Patent biliteral lilac and femorel GlrGvlation.
Continuation of medicI. tre8tm8~t ia recommended. A target LDL value of less than 80 il

recommended . After'oad reducing therapy II ,.commended because of mlltal
regurgltaUon . Endocarditis prophyl8:ICI8 aglinat bacterial endoc.rdili. i. recommended.
Dr. Murlhy. kind referral Is greatly apprec1lled.
Asad U. Qamar, M.D . FCCP. FSGC, FACe, FACP. F$C&I
AUQ: pb
D: 09/08/2005
T: 09/1212005 10:48:00
299827
cc: Dr. Murthy
Chert Copy
Page 3 of 3
04: 55pm From-FPHCfax ~ +3528736182 T-562 P.002/002 F-362

e h I C'R bo I , I PICI L rillOI 2 fire] la11l111 leper L f 1') +35!173'182i 24 JAI 0' I': ~ 9
DOCTORS LABORATORY INC.
DIRECTOR 2Q06 JULIA DRIVEl VALDOST~ CEQRCIA 31&04
JACKSON GATES, M.D. PHONE (229)244-44'9
I
PAIIENT: aILL~SPIE~PENELOPE I SEX.SP: F
PT PRONE! FASTINC: NO CQLL~CTgD= 01/26/200'-10:15 ~M
ACCESSIO ; 86281D9 AOE,DOB: ,~,I0/29/1930 RECEIVED~ Ol/24/200'-11!48 AM
PT ID.; K/G REO~; , REPORTEb: 01/24/2006-4:50 PM
MED gEe#: 310035 RM#: ROUTE/STDP~ 9S01 PACE 1
PHYSICIA ORAINCER
CLIENT: FLORIDA PALLIATIVE HOME CARE ACCOUNT NO. 425440
9504 SW 110TH ST
OCALA, FL 34471
----~-----
TEST ------~--~ ~ITUIN RANCE ..
_~~------~~~---~------~---~----------------~---------~----
OUTSIDE RANCE NORMAL RANCE UNITS
DIGOXIN 0.' O.5 2.0

Mo NG/ML
FAX TO 352 91 5136 AND TO DR.GRAINGER
*** FINAL REPORT ~
EXCEPT WHE TEST PERFORMED AT DOCTORS LABORATORY INC., VALDOSTA, CA
.!It F~~~~
~.
~k4G~4
10/11/2005 15:35 FAX 352 732 aD)4 raJ 004

) "J
10/11/05 Lab Result Report Page 1
Quest Diagnostics Inc. OCALA FAMILY PHYSICIANS, PA
4223 East Fowler Avenue 3515 SE 17th Street
Tampa, FL 33617 Ocala, FL 34471
Patient: GILLESPIE, PENELOPE M SSN: 18024-0035 Date Drawn Date Received Date Reported
Requisition: TPM058001242A Patient # 24200.0 09/27/2005 0912812005 09/2812005
Sex: F DaB: 10/29/1930 Age: 74 y 10 m Chart # 24200.0 2:13A
Fasting: Y
Report Status: COMPLETE
Client Note: MORGAN, GLEN A Lab Specimen 10: TP783659I
Provider: MORGAN, M.D., GLEN Lab Account: 44001588
TRlGLyeERIDES
TRIGLYCERIDES 152 H MG/DL <150 TP
CHOLESTEROL, TOTAL
CHOLESTEROl,TOTAL 186 N MGlDL <200 TP
HDL CHOLESTEROL
HOl CHOLESTEROL 57 N MGlDL >OR=40 TP
LDL-cHOLESTEROL
LDL-eHOLESTEROL 99 N MG/DL (CALC) <130 TP
CHOUHDLC RATIO
CHOUHDLC RATIO 3.3 N (CALC) <4.4 TP
COMPREHENSIVE METABOLIC PANEL

GLUCOSE 81 N MG/DL 65-99 TP
FASTING REFERENCE INTERVAL
UREA NITROGEN (BUN) 26 N MGIDL 730 TP
CREATININE 1.1 N MG/DL 0.5-1.2 TP
BUN/CREATININE RATIO 24 N (CALC) 6-25 TP
SODIUM 142 N MMOUL. 135-146 TP
POTASSIUM 3.8 N MMOUL 3.5-5.3 TP
CHLORIDE 101 N MMOUL 98-110 TP
CARBON DIOXIDE 27 N MMOUL 21-33 TP
CALCIUM 9.0 N MGIDL 8.5-10.4 TP
PROTEIN. TOTAL 6.6 N GlDL 6.0-8.3 TP
ALBUMIN 3.6 N GIDL 3.2-4.6 TP
GLOBULIN 3.0 N GlDl(CALC) 2.2-4.2 TP
ALBUMIN/GLOBULIN RATIO 1.2 N (CALC) 0.8-2.0 TP
BILIRUBIN. TOTAL 0.7 N MGIDL 0.2-1.3 TP
ALKALINE PHOSPHATASE 68 N U/L 20-125 TP
AST 25 N U/L 2-35 TP
ALT 17 N UIL 2-40 TP
cae (INCLUDES DIFFIPLT)

WHITE BLOOD CELL COUNT 8.0 N THOUSlMCl 3.8-10.8 TP
RED BL.ooD CELL COUNT 4.04 N MILUMCL 3.80-5.10 TP
HEMOGLOBIN 12.7 N GIDL 11.7-15.5 TP
HEMATOCRIT 38.1 N % 35.G-45.0 TP
Mev 94.2 N FL 80.0-100.0 TP
MCH 31.5 N PG 27.0-33.0 TP
MCHC 33.4 N GlOL 32.0-36.0 TP
ROW 15.7 H % 11.0-15.0 TP
PLATELET COUNT 270 N THOUs/Mel 140-400 TP
ABSOLUTE NEUTROPHILS 5000 N CELLSIMCL 1500-7800 . TP
ABSOLUTE LYMPHOCYTES 1904 N CELLSlMCL 850-3900 TP
ABSOLUTE MONOCYTES 632 N CELLS/MeL 200-950 TP
ABSOLUTE EOSINOPHILS 408 N CELLSIMCL 15-500 TP
ABSOLUTE BASOPHILS 58 N CELLSIMCL 0-200 TP
NEUTROPHILS 62.5 N % TP
LYMPHOCYTES 23.8 N % TP
MONOCYTES 7.9 N % TP
EOSINOPHILS 5.1 N % TP
BASOPHILS 0.7 N 0/0 TP
10/11/2005 15:35 FAX 352 732 6934 [gJ 005
")
10/11/05 Lab Result Report Page 2
Quest Diagnostics Inc. OCALA FAMILV PHYSICIANS, PA
4223 East Fowler Avenue 3515 SE 17th Street
Tampa, FL 33617 Ocala, FL 34471
Patient: GILLESPIE, PENELOPE M SSN: 180-24-0035 Date Drawn Date Received Date Reported
Requisition: TPM058001242A Patient # 24200.0 09/27/2005 09/2812005 09/2812005
Sex: F DaB: 10/29/1930 Age: 74 y 10m Chart # 24200.0 2:13A
_Ut.__ m_.
Fasting: Y
Report Status: COMPLETE
Client Note: MORGAN, GLEN A Lab Specimen 10: TP783659I
Provider: MORGAN, M.D. GLEN Lab Account: 44001588
ft. . . . . . . . .'
TSH
TSH 4.29 N MIU/L 0.40-5.50 TP
VITAMIN 812
VITAMIN 812 904 N PGIML 200-1100 TP
performing Laboratory Site Legend ...
TP
QUEST DIAGNOSTICS-TAMPA
4225 E. fOWLBR AVE
TAMPA, FL 33617
rlill'~~ I~~ ;I PHARMACY PH (352)854-9600
NDC 65726-0261-25 DR A. QAMAR
PATIENT PENELOPE GILLESPIE Our records show that you have reported no allergies:
MEDICATION RYTHMOL SR 225MG CAPSULES WHITE
QUANTITY 10
DIRECTIONS TAKE 1 CAPSULE BY MOUTH TWICE
DAILY ~CC)A
Side 1: A 225 Our records show that you have reported health conditions.
INGREDIENT NAME:
PROPAFENONE (proe-pa-FEEN-none)
COMMON USES:
This medicine is a Class 1C ant7'-arrhhmic medicine used to treat an irregular heartbeat and to help maintain a normal heart rhythm in patients without
structural heart disease.
BEFORE USING THIS MEDICINE:
WARNING: This medicine has not been shown to improve the rate of survival in patients with an abnormal heart rhythm. For this reason, this medicine
should only be used for certain life-th~eate.n.iog, abnormal heart rhythms. Talk wrrh your doctor about the risks and benefits of using this medicine. Some
medicines or medical conditions may Interact with this medicine. INFORM YOUR DOCTOR OR PHARMACIST of all prescription and over-the-counter medicine that
you are taking. DO NOT TAKE THIS MEDICINE if you are also taking other medicines that affect heart rhythm (such as amiodarone, sotalol, or quinidine),
pimozide, droperidol, bepridil, cisapride, HIV protease inhibitors (such as ritonavir or saquinavir), macrolide antibiotics (such as erythromycin,
clarithromycin, or azithromycin), telithromycin, quinolone antibiotics (such as levofloxacin, moxifloxacin, or sparfloxacin), phenothiazine medicines (such as _
promethazine), certain medicines for deRression (tricyclics such as imipramine or desipramine), or ziprasidone. Contact your doctor for more information. ~
ADDITIONAL MONITORING OF YOUR DOSE OR CONDITION may be needed if you are taking arsenic, blood thinn~.r..s.Jsuch as warfarin), beta-blockers (such as
propranolol or metoprolol), digoxin, mexiletine, rifampin, cimetidane cyclosporine, certain medicines forttel'TesSTon (such as venlafaxine, duloxetine,
fluoxetine, or citalopram), certain anti-nausea mediCines (such as dolasetron or ondansetron), certain anti-fungal medicines (such as ketoconazole), or certain
()
asthma medicines (such as theophylline or aminophylline). DO NOT START OR STOP any medicine without doctor or pharmacist approval. Inform your doctor of any
other medical conditions, includin9.- use of an artificial pacemaker, liver problems, kidney problems, myasthenia gravis, allergies, pregnancy, or breast-feeding.
USE OF THIS MEDICINE IS NOT RECOMMENDED if you have certain types of irregular heartbeat (such as sick SinUS node syndrome or atrioventricular block)
and you are not using an artificial pacemaker, certain breathing problems (such as chronic bronchitis or emphysema), slow heart rate, very low blood pressure, ~
heart failure (such as congestive heart failure), abnormal electrolyte levels in your blood, or certain shock conditions. Contact your doctor or pharmacist if
you have any questions or concerns about taking this medicine.
HOW TO USE THIS MEDICINE:
Follow the directions for using this medicine Rrovided by your doctor. SWALLOW WHOLE. Do not break, crush, or chew before swallowing. This medicine may
be taken on an em~ty stomacn or with food. Take each dose at the same time with respect to meals. Take this medicine at evenly spaced times throughout the day
and night. STORE THIS MEDICINE at room temperature at 77 degrees F (25 degrees C) In a tightl'l-c1osed container away from heat and light. Take this
medicine regularly to receive the most benefit from it. Do not to miss any doses. IF YOU MISS A DOSE OF THIS MEDICINE, take it as soon as possible. If
it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.
CAUTIONS:
DO NOT TAKE THIS MEDICINE if you have had an allergic reaction to it or are allergic to any ingredient in this product. DO NOT EXCEED THE
RECOMMENDED DOSE. DO NOT SUDDENLY STOP TAKING THIS MEDICINE without checking with your doctor. Some conditions may become worse when the
medicine is suddenlr stopped. Laboratory and/or medical tests, including EKGs, may be~erformed to monitoryour progress or to check for side effects. KEEP
ALL DOCTOR AND ABORATORY APPOINTMENTS while you are taking this medicine. BEFORE YOU HAVE ANY MEDICAL OR DENTAL TREATMENTS, EMERGENCY
CARE, OR SURGERY, tell the doctor or dentist that you are using this medicine. THIS MEDICINE MAY CAUSE dizziness or drowsiness. Do not drive, operate
machinery, or do anything else that could be dangerous until you know how you react to this medicine. Using this medicine alone, with other medicines, or with
alcohol may lessen your ability to drive or to perform other potentially dangerous tasks. EATING GRAPEFRUIT OR DRINKING GRAPEFRUIT JUICE while you
are taking this medicine may increase the amount of this medicine in ypur blood, which may increase your risk for serious side effects. Talk with your doctor
before including grapefruit or grapefruit juice in your diet. BEFORE YOU BEGIN TAKING ANY NEW MEDICINEJ either prescription or over-the-counter, check
with your doctor or pharmacist. FOR WOMEN: IF YOU PLAN ON BECOMING PREGNANT" discuss with your aoctor the benefits and risks of using this medicine
during pregnancy. THIS MEDICINE IS EXCRETED IN BREAST MILK. DO NOT BREAST-FEt:D while taking this medicine.
POSSIBLE SIDE EFFECTS: ' . ~ ., /------.-----.~ ~...---_., .")
SIDE EFFECTS that may occur while taking this medicine include dizziness or lightheadedness,.~~w~ine.ss,..eOnstipation, gas, ired ss{ or change in
taste. If they continue or are bothersome, check with your doctor. CONTACT YOUR DOCTOR ~TELY if you expenence c e~~tnus-\nll.bwisio~r
bleeding, irregular heartbeat, fast or slow heartbeat,...shortness of breath, swelling of the hands or the feet, fever, sore throat,l.. chills, ined ~qkne$..,-=='
muscle weakness, tremor, blurred vision.....ofQIttnc~d diarrne~weating, vomiting, or loss of appetite or thirst. AN ALLERGIC r1EACTION to this me IClne IS
unlikely, but seek immediate medical atte-nti'Oi1lTlt occurs.ymptoms of an allergic reaction include rash, itching, swelling, dizziness, or trouble breathing.
If you notice other effects not listed above, contact your doctor, nurse, or pharmacist.
OVERDOSE:
If overdose is suspected, contact your local poison control center or emergency room immediately. Symptoms of overdose may include fast or slow heartbeat,
decreased sexual ability, seizures, severe dizziness or drowsiness, weakness, fatigue, and metallic taste.
ADDITIONAL INFORMATION:
DO NOT SHARE THIS MEDICINE with others for whom it was notj)rescribed. DO NOT USE THIS MEDICINE for other health conditions. KEEP THIS
MEDICINE out of the reach of children. IF USING THIS MEDICINE FOR AN EXTENDED PERIOD OF TIME, obtain refills before your supply runs out.
KEEP OUT OF REACH OF CHILDREN - STORE IN SAFETY CONTAINERS OR SECURE AREA

8
~
)~~ WINN-DIXIE PHARMACY #
::\~;:,T .;~,,~':'\.
atWlon:JI:de'"
Rk#:6817408
8445 SW HWY 200 SUITE 131
OCALA, FL 32676
Ph: 352 854.2464
01/24/06
2289
et I
PfJif~7")Y;:3\i'
atWlnn~lxt~
RX#: 6817408
WINN-DIXIE PHARMACY # 228
8445 SW HWY 200 SUITE 131
OCALA, FL 32676
Ph: 352 854-2464 NCPDP: 1070755
01/24/06
~
Drug Utilization RCV1~W
..
W 1. Imp~rtant to read the Med -lcatlOn .
GUide before use
2. AVOId prolonged exposure to ~un.Use sunscr~en
3. Not. recommen~ed fo~ use while breast-feeding
TIP Auth #: 731EQLW . 4. Notify your Dr If you Intend to become pregnant
OOB: 10/29/30 Tx#..1546363 5. Consult Dr/Pharmacist before taking non-RX meds

GILLESPIE, PENELOPE PH #: 352 854-7807 ea~ner: MOe 6. Promptly report unusual symptoms/effects to Dr
8092 SW 115 LOOP DL #: OS. 30 NEW 7. Inform Dr/Dentist prior to any type of surgery.
OCALA, FL 34481 8. If blue-,gray skin color occurs -Notify doctor.
QAMAR, ASAD MD 111111111111111111111111111111 SIDE1: E 144
SIDE2: DUR INFORMATION:
AMIODARONE 200MG TAS EO EON LABS ~~6~~: ~I~~~E~ELLOW TABLET 2 DD DRUG-DRUG INTERACTION /1 'T".! . '"\
SHAPE~ ROUND D1 :D1GOXIN :11 ~ .1
NDe: 00185-0144-60 Your Cost $40 .44 j _ ').:7 ~ Db
Disp Qty: 30.00 TAB Refills: 3 by 01/24/07 t
You saved $ 10.51 by ~.J"'. ~ ,? I~ J ... ' '\-1

ynUR COST: $40.44 using your plan ->,evC-- ?/1/DCt'i-"':;:")J::'"
j . (t--~,~)
~ WINN-DIXIE PHARMACY /'

. . ,..' ,(!fjJ D:fYO\l ~~il'...myquesti0i1~,Please cont,\ct your WUltl-DiXll'; phalmacl't .oJ
\i;~>~_:~;'.\i ,~_:'.,
AMIODARONE 200MG TAB EONL :F~~mp _././~' PHONE #(352) 854-2464 .
,.i i,cu TAK E ONE TABLET BY MOUTH EVERY DAY
GENERIC NAME: AMIODARONE (a-MEE-oh-da-ronel ~i~
61. d.
{/if I Ii,,-- Z -3 /)}.y:
;>
t:
.' Lo
,.J
L t '" [,
C;:lsr),
~ (;J,-]~ Ii dV,""
COMMON USES: This medicine is an antiarrhythmic used to treat an irregular heartbeat an~ to maintain a normal heart #:'It'k~
rate. It may also be used to treat other conditions as determined by your aoctor. 'yk.t:"-.....
BEFORE USING THIS MEDICINE: WARNING: Amiodarone therapy should only be started in a hospital.under close medical
supervision in pa~ients with cert~in 'types of life-threa~~ningjrfegula~heartb.e~t.<~er.lous.s.i.de...ef~ects, i~~ludiog .severe: I~ng
problems (sometimes fatal) and liver problems (rarely fatal), have occurted In patients taking thiS medicine. This medicine
may infrequently make an irregular heartbeat worse. Amiodarone should be uS.ed only when other.,medicines have not
worked. It may take 2 weeks or longer for this medicrne to work. Your doctor should monitor your condition closely and
may adjust your dose of this medicine periodically. Amiodarone may stay in your body for a period of time after you stop
taking it. If you need to take other medicines which may interact with this medicine, caution is advised both while you are
taking the medicines together and for several months after you stop taking amioda.rone. It-is possible ,tbat aQ.jrr.e_g~ular,
heartbea~ corrected qy this m.edic,in~ cC?~ld r~~~r~yvithin vyeeks to .~o~ths aft~r~y.Qu.stop taki.ng it_~ ~<?nsult 'lour doctor or
pharmaCist for more Information. Some m'edlclnes or"medlcal- conditions may Interact with thiS mediCine. INFORM YOUR
DO'CTOR/PHARMACIST of all prescription and over-the-counter medicine that you are taking. DO NOT TAKE THIS
MEDICINE if you are also taking cisapride, astemizole, terfenadine, agalsidase beta, dofetilide, ibutilide, HIV protease
inhibitors (such as nelfinavir or ritonavir), certain medicine for erectile problems (such as vardenafil), ~uinupnstin, or
dalfoRristin. Radioactive iodine therapy should not be used while you are taking this medicine. ADDITIONAL MONITORING
OF YOUR DOSE OR CONDITION may be needed if you are taking "blood thinners" (such as warfarin), arsenic,
beta-blockers (such as propranolol or metoerolol), cimetidine, cyclosporine,. d,igoxin, calcium channel blockers (such as
diltiazem or verapamil), droperidol, certain 'statin" cholesterol medicines (sucn as simvastatin or atorvastatin), certain
seizure medicines (such as phenytoin), other medicine for irregular heartbeat (such as disopyramide, encainide, flecainide,
procainamide, propafenone, quinidine, lidocaine, or sotalol), certain narcotic medicines (such as fentanyl), phenothiazines
(such as thioridazine), pimozide, rifampin, ziprasidone, quinolone antibiotics (such as sparfloxacin and levofloxacinL
macrolide antibiotics (such as erythromycin and clarithromycin), telithromycin, certain antifungal medicines (such as
ketoconazole or itraconazole), dextromethorphan, cholestyramine, methotrexate, St. John's wort, medicine for depression,
medicine for diabetes, or any medicine that may decrease the level of potassium or magnesium in your blood (such as
"furosemide or hydrochlorothiazide). If you have questions about whether any of ~our medicines may decrease potassium or
magnesium levels, check with your doctor or pharmacist. DO NOT START OR STOP any medicine without doctor or
pharmacist approval. Inform your doctor of any other medical conditions including liver problems, lung or breathing
problems, other heart problems (such as congestive heart failure, blood pressure problems, or severe left ventricle
problems), thyroid problems~ electrolyte problems such as low potassium or magnesium levels, allergies, rregnanc y , or
breast-feeding. USE OF THI~ MEDICINE IS NOT RECOMMENDED-'if you have a flistory of certain types 0 irregular
heartbeat or neart rhythm (such as severe sinus node dysfunction resulting in unusually slow heart rate, severe sinus block,
second or third degree atrioventricular block, or slow heart rate that has caused dizziness or fainting), or untreated low
blood levels of potassium or magnesium. Contact your doctor or pharmacist if you have any questions or concerns about
taking this medicine.
HOW TO USE THIS MEDICINE: Follow the directions for using this medicine provided by your doctor. This medicine
comes with a MEDICATION GUIDE. Read it carefully each time you refill this medicine. Ask your doctor, nurse, or
pharmacist any questions that you may have about this medicine. PJSCUSS WITH: Y,O_UR.D.O.CTO-Flhwhether to. ta~e your
dose wit~ or without. food. It. is very _important to take this medicine 'cbnsistent!y with reg_ard to foo,O. ~sk your doctt;>r'''or
pharmaCist for more Information. AVOID.EATING GRAPEFRUIT OR. DRI.NKING GRAPEFRlJITJU1CEi.!hwhlle you are taking
this medicine. STORE THIS MEDICINE at room temperature at 77 degrees F (25 degrees C) in a tightly-closed container,
away from heat and light. Take this medicine re9.ularly to receive the most benefit trom it. Taking this medicine at the same
time each day will help you to remember. IF YOU MISS A DOSE OF THIS MEDICINE, skip the missed dose and go back to
your regular dosing schedule. Do not take 2 doses at once.
CAUTIONS: DO NOT TAKE THIS MEDICINE if you have had an allergic reaction to it or are ~lI.ergJc"to any ingredJ~nt in this
product, including iodine. IT MAY TAKE SEVERAL WEEKS for this medicine to work. DO NOT"~'STOP TAKING this medicine'
or change your dose without checking with your doctor. Some conditions may become worse when the medicine is
suddenly_stopped or when more medicine is taken than prescribed. Laboratory and/or medical tests, including physical
exam, EKG, chest x-rays, blood tests, lung function tests, ,liver fl.Jnction tests, th:troid function tests, and eye exams may
be performed to monitor your progress or check for side effects:'KEEP-'ALL DOCTOR AND LABORATORY APPOINTMENTS
while. you are taking this medicine. BEFORE YOU HAVE ANY MEDICAL OR DENTAL TREATMENTS, EMERGENCY CARE,
OR SURGERY, tell fhe doctor or dentist that you are usin~this medicine. This medicine may cause dizziness. DO NOT
DRIVE, OPERATE MACHINERY, OR DO ANYTHING ELSE-THAT COULD BE DANGEROUS until you know how you react to
this medicine. Using this medicine alone, with other medicines, or with alcohol may lessen_your ability to drive or to
perform other potentially dangerous tasks. VERY RAR,ELY,CASES OF PE~MANENT .SLIN.DNESS have been reported with
fih WINN-DIXIE PHARMACY
rf!:::f if you have' tstions, please i:omacl 'wOjjJ '~,' ,n.:'c,r;' n;;,n:,L
Ph.~nn3";.y
at Wlnn-D11d8 .
NE j~
,
use of this medicine. Tell your doctor immediately if you experience any vision changes. THIS MEDICINE MAY CAUSE
increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to
this medicine. Use a sunscreen or protective clothing if you must be outside for a prolonged period of time. Long-term
therapy with this medicine may infrequently cause a blue-gray discoloring of the skin. Fair skin or excessive sun exposure
may Increase your risk. Risk may also be related to your total dose or length of therapy. This effect is not harmful and
usually reverses, sometimes incompletely, after Y9U stop taking this medicine. Discuss any concerns with your doctor.
BEFORE YOU BEGIN TAKING ANY NEW MEDICINE, either prescription or over-the-counter, check with ~our doctor or
Qharmacist. This includes cough medicines or any medicine that contains cimetidine. CAUTION IS ADVISED WHEN USING
THIS MEDICINE IN THE ELDERLY because they may be more sensitive to the effects of this medicine. FOR WOMEN: THIS
MEDICINE HAS BEEN SHOWN TO CAUSE HARM to the human fetus. IF YOU PLAN ON BECOMING PREGNANT, discuss
with your doctor the benefits and risks of using this medicine during pregnancy. THIS MEDICINE IS EXCRETED IN BREAST
MILK. DO NOT BREAST-FEED while taking this medicine.
POSSIBLE SIDE EFFECTS: SIDE EFFECTS that may occur while taking this medicine include tiredness, constipation, loss of
appetite, taste or smell changes, nausea, vomiting, dizziness, trouble sleeping, headache, flushing, stomach pain,
decreased sexual interest, or changes in the amount of saliva you Rroduce. If they continue or are bothersome, check with
your doctor. CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience tremor or uncontrolled muscle
movements; loss of coordination; tingling or numbness of hands, legs, or feet; muscle weakness; burning or tingling of the
skin; unusually dry eyes; swollen neck; unusual sweating; restlessness, nervousness, or anxiety~ intolerance to heat or
cold; unexplained weight change; hair loss; or menstruar changes. CONTACT YOUR DOCTOR IMMEDIATELY if you
experience fever; wheezing; unexplained cough; coughing up Dlood; difficult or painful breathing; chest pain; severe nausea
or vomiting; severe stomach pain; yellowing of the eyes or skin; dark urine; severe or persistent tiredness; swelling of the
hands or feet; slow, fast, or irregular heart6eat; severe dizziness or lightheadedness; fainting; vision changes (such as
seeing halos, blurred vision, light sensitivity, or loss of vision); unusual bruising or bleeding; persistent sore throat; or
reddened, swollen, or blistered skin. AN ALLERGIC REACTION to this medicine is unlikely but seek immediate medical
attention if it occurs. Symptoms of an allergic reaction include rash, itching, swelling, severe dizziness, or trouble
breathing. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist.
OVERDOSE: If overdose is suspected, contact your local poison control center or emergency room immediately. /
Symptoms of overdose may include severe dizziness, unusually slow pulse, or fainting.
ADDITIONAL INFORMATION: Your doctor may want you to check your pulse rate every day while you take this Ledicine.
Learn how to monitor 'Lour pulse. Carry an identification card at all times that savs 'LoU are taking thiS medicine~O NOT
SHARE THIS MEDICINE with others for whom it was not prescribed. DO NOT USE THIS MEDICINE for other health
conditions. KEEP THIS MEDICINE out of the reach of children and pets. IF USING THIS MEDICINE FOR AN EXTENDED
PERIOD OF TIME, obtain refills before your supply runs out.
GILLESPIE, PENELOPE
\[: Dl~- -\1 j,.f\l AMIODARONE 200MG TAB EONL
e information in thi~ n:'0nogral?h i~ not intef}ded to c~ver al,l possible uses, 9irection,s, prec~utions, drug interactions, or
adverse effects. ThiS Information IS generalized and IS not Intended as speCifiC medical adVice. If you have questions about
the medicines you are taking or would like more information, check with your doctor, pharmacist, or nurse.
~gg~right 2006 Wolters Kluwer Health, Inc. All rights reserved. Database Edition 06.1 Information Expires February 22,
Page 1 of 2
Neil Gillespie
From: "John" <john@jcwillislaw.com>

To: <neilgillespie@mfi.net>
Cc: <flossie@jcwillislaw.com>
Sent: Tuesday, July 24, 2007 1:16 PM
Subject: FW: GILLESPIE, NEIL - Possible Med Mal
Mr. Gillespie,
Maura Ramage at BMM asked that I contact you about the care and treatment your mother
received. From what you have stated medical negligence may well have occurred. Without
reviewing the medical records and consulting with an expert cardiologist I am not am to state
with any degree of certainty that is the case. Medical negligence cases are expensive and very
time consuming to pursue. Given that your mother has made a good recovery, albeit with
some degree of kidney dysfunction, I am concerned that the costs expended in pursuing this
matter could very well outweigh any recovery. Under the circumstances, I am not in a position
to represent your mother in this matter.
You may want to consider filing a complaint with the Agency for Health Care Administration
(AHCA). They are obligated per Florida law to investigate the matter if a complaint is filed.
Sincerely,
John Willis
_________________________________________________
From: Neil Gillespie [mailto:neilgillespie@mfi.net]
Sent: Monday, July 23, 2007 10:53 AM
To: Maura Ramage
Subject: Re: Possible Medical Malpractice Matter
July 23, 2007

Dear Ms. Ramage,
Thank you for your reply. This is a request for an evaluation of whether improper medical treatment
provided to my mother by "cardiologist A" amounts to medical malpractice. I am my mothers caregiver
and manage her affairs.
The facts in this matter are as follows: a 75 year-old female with chronic atrial fibrillation or A-fib (4+
years) was given a new treatment plan by cardiologist A of anti-arrhythmic drug (Rythmol) preparatory
to cardioversion, for the purpose of restoring the hearts normal rhythm. I later learned from
"cardiologist B" (and others) that this treatment plan was completely inappropriate, given the fact that
moms A-fib was chronic, 4+ years. Chronic A-fib does not respond to cardioversion, because after six
months or so of arrhythmia the hearts "memory" is resistant to change.
After taking Rythmol for two weeks, mom had an adverse reaction, became orthostatic, and was
hospitalized (Dec-06-05 to Dec-23-05, West Marion Community Hospital) followed by inpatient
12/27/2015
Page 2 of 2
nursing care (Dec-23-06 to Jan-10-06, TiberRidge Nursing and Rehabilitation). Moms hospitalization
was marked by gastrointestinal complications and other issues and appeared life threatening. The
medical costs exceeded $80,000.00 and was covered by insurance.
After moms release from the nursing home in January, 2006, cardiologist A persisted with his treatment
plan of anti-arrhythmic drug (now Amiodarone) preparatory to cardioversion, even after the previous
catastrophic sequence of events.
I sought a second opinion with cardiologist B, who said the previous treatment was contraindicated.
Cardiologist B has been successfully treating mom by managing her A-fib. All of moms other doctors
concur, including two primary care physicians, her neurologist, and other specialists. My mother
recovered, but suffered declining kidney function, currently stable at 25%-30%.
Did cardiologist As treatment of moms chronic A-fib with anti-arrhythmic drugs and proposed
cardioversion amount to malpractice, and did it result in my mothers unnecessary hospitalization, pain,
suffering, and permanent kidney damage?
Thank you for your consideration.

Neil Gillespie
8092 SW 115th Loop
Ocala, FL 34481
(352) 854-7807
----- Original Message -----

From: Maura Ramage
To: neilgillespie@mfi.net
Cc: Ranier Munns ; zzbmm
Subject: Possible Medical Malpractice Matter
Dear Mr. Gillespie: Please accept our apologies that you have not heard back from us regarding your
inquiry of a possible medical malpractice claim. I do not know what happened but for some reason I never
received your email. If you would be so kind as to forward the details of the situation to my attention, I will
certainly be happy to have Mr. Munns review the matter. Again, I apologize for the delay and look forward
to hearing from you. Sincerely, Maura, Secretary to Ranier Munns.
_______________________________________________
From: Neil Gillespie [mailto:neilgillespie@mfi.net]
To: zzbmm
Subject: representation
Importance: High
July 23, 2007

Mr. Ranier Munns,
On July 15, 2007 I sent you an email about a possible medical malpractice matter. Because you did not
respond, I take that to mean that you and your firm are not interested, and I will proceed on that basis,
and seek other counsel. Thank you.
Neil Gillespie
12/27/2015
Page 1 of 1
Neil Gillespie

To: <bmm@boginmunns.com>
Sent: Sunday, July 15, 2007 3:04 PM
Subject: medical malpractice representation
July 15, 2007
Mr. Ranier Munns,
This is a question about whether inappropriate medical treatment provided to my mother by

"cardiologist A" amounts to medical malpractice. I am my mothers (Penelope Gillespie) primary
caregiver, and have power of attorney to manage her affairs.
Facts: 75 year-old female patient with chronic A-fib (4+ years) with angina was given new treatment
plan of anti-arrhythmic drug (Rythmol) preparatory to cardioversion, by cardiologist A. I later learned
from cardiologist B (and others) that this treatment plan was completely inappropriate, given the fact
that the A-fib was chronic, 4+ years. Chronic A-fib does not respond to cardioversion, because after
six months or so of arrhythmia the hearts "memory" is resistant to change.
After taking Rythmol for two weeks, patient had adverse reaction, severe diarrhea, became
orthostatic, and was hospitalized (Dec-06-05 to Dec-23-05, West Marion Community Hospital)
followed by inpatient nursing care (Dec-23-06 to Jan-10-06, TiberRidge Nursing and Rehabilitation).
Patients hospitalization was marked by severe gastrointestinal and issues related liver and kidney
function, and appeared life threatening. The medical costs approached $100,000.00 and were covered
by insurance.
After moms release from the nursing home in January, 2006, cardiologist A persisted with his
treatment plan of anti-arrhythmic drug (now Amiodarone) preparatory to cardioversion, even after the
previous catastrophic sequence of events.
I sought a second opinion with cardiologist B, who said the previous treatment was contraindicated.
Cardiologist B has been successfully treating mom by managing her A-fib. All of moms other
doctors concur, including two primary care physicians, her neurologist, and other specialists. My
mother recovered, but suffered declining kidney function, currently stable at 25%-30%.
Question: Did cardiologist As treatment for A-fib with anti-arrhythmic drugs and proposed
cardioversion amount to malpractice, and did it result in my mothers unnecessary hospitalization,
pain, suffering, and permanent kidney damage?
Thank you for your kind consideration.
Sincerely,
Neil J Gillespie
8092 SW 115th Loop
Ocala, FL 34481
(352) 854-7807
neilgillespie@mfi.net
12/27/2015
c
LAW Oll'FJCE ()F 2815 N\V 13th Street
Suite 200
ROBERTW. BAUER, P.A. Gainesville, FL 32609
Tele: 352.375.5960
Fax: 352.337.2518
Internet address:
R\XIB@bauerlegal.c01TI
August 2, 2007
Neil Gillespie
8092 SW I 15th Loop
Ocala, FL 34481
Ref: Malpractice Evaluation
Dear Mr. Gillespie:
Generally, I do not do Inedical malpractice. However, I aln aware of saIne of the requirenlents for
it. In order to do an accurate evaluation of this case, we would need to send it off to medical
experts to determine whether or not they felt that this was actually medical malpractice. To do
that, I would need a copy of your Inother's medical files and it will cost approximately $600 to
have the medical experts perfOrlTI the evaluation. I would further advise a case evaluation done by
a firlll who does jury verdict asseSSlnents that I have used in the past. I believe it is approxilnately
$200 for their services.
You Inay also wish to contact another firm who specializes in medicallnalpractice and see if this
is a case that they would be interested in. Please recall that in any situation there is an applicable
statute of limitations, which Jnay be as short as one year in this case. If you fai I to have your case
filed within the statute of lilnitations, your Inother would lose her case.
Sincer~~
~ ..
. :&
/.~~~.-
Robert W. Bauer, Esq.
RWB/kam
""" r ''7 mil ']'"' 1 1 1 1 HI ,,,.-.,, II r 1 f 1_ _ 1 ___ 11 1 n rill' !' ,
ROBERT W BAUER, ESQ. $0.41 ~

us POSTAGE
28,15 {'JV\I 13TH 8T STE 20C'E FIRST-CLASS
FROM 32609
GAINESVILLE, FL 32609 AUG 02 2007
stam~
.rom
II .11 111 .. Iii u 11111,.11, .11111111.1.1.11.11, LI.ill u 1.1111111111111

Ne,1 Glliespie
8092 S\~ 115th Loop
Ocala r:'L 34431-3567
e
1 11 1,1 i .11111111.1 .111111111.1 11 111.11.1 111.11 1. ~
U k
Neil J Gillespie
8092 SW 115th Loop
Ocala, FL 34481
Telephone: (352) 854-7807

email: neilgillespie@mfi.net
July 21, 2007
Robert W. Bauer, Esquire

Law Office of Robert W. Bauer, P.A.
2815 NW 13th Street, Suite 200E
Gainesville, FL 32609-2865
Dear Mr. Bauer,
This is a request for an evaluation of whether improper medical treatment

provided to my mother by cardiologist A amounts to medical malpractice.
The facts in this matter are as follows: a 75 year-old female with chronic atrial
fibrillation or A-fib (4+ years) was given a new treatment plan by cardiologist A of anti-
arrhythmic drug (Rythmol) preparatory to cardioversion, for the purpose of restoring the
hearts normal rhythm. I later learned from cardiologist B (and others) that this
treatment plan was completely inappropriate, given the fact that moms A-fib was
chronic, 4+ years. Chronic A-fib does not respond to cardioversion, because after six
months or so of arrhythmia the hearts memory is resistant to change.
After taking Rythmol for two weeks, mom had an adverse reaction, became
orthostatic, and was hospitalized (Dec-06-05 to Dec-23-05, West Marion Community
Hospital) followed by inpatient nursing care (Dec-23-06 to Jan-10-06, TiberRidge
Nursing and Rehabilitation). Moms hospitalization was marked by gastrointestinal
complications and other issues and appeared life threatening. The medical costs
exceeded $80,000.00 and was covered by insurance.
After moms release from the nursing home in January, 2006, cardiologist A
persisted with his treatment plan of anti-arrhythmic drug (now Amiodarone) preparatory
to cardioversion, even after the previous catastrophic sequence of events.
I sought a second opinion with cardiologist B, who said the previous treatment
was contraindicated. Cardiologist B has been successfully treating mom by managing
her A-fib. All of moms other doctors concur, including two primary care physicians, her
neurologist, and other specialists. My mother recovered, but suffered declining kidney
function, currently stable at 25%-30%.
Robert W. Bauer, Esquire Page - 2
July 21, 2007
Did cardiologist As treatment of moms chronic A-fib with anti-arrhythmic drugs
and proposed cardioversion amount to malpractice, and did it result in my mothers
unnecessary hospitalization, pain, suffering, and permanent kidney damage?
Sincerely,
Neil J Gillespie
Page 1 of 1
Neil Gillespie
From: "Stephen Knox" <SKnox@forthepeople.com>

Sent: Wednesday, August 22, 2007 10:48 AM
Subject: Potential Malpractice
Dear Mr. Gillespie,
Thank you for your recent letter regarding your mother. The answer to your question is that if a cardiologist
testifies under oath that another cardiologist was negligent ant that the negligence resulted in injury to your
mother then you have a case for any injuries or damages caused by the negligence.
Due to the expense of malpractice litigation this is not a case that I can pursue for you.
Thank you,
Stephen J. Knox
12/27/2015
Neil J Gillespie
8092 SW 115th Loop
Ocala, FL 34481
Telephone: (352) 854-7807

August 17, 2007
Stephen J. Knox, Attorney at Law

20 North Orange Street, Suite 1600
Orlando, FL 32801
Tel: (407) 420-6953
Dear Mr. Knox,

provided to my mother by cardiologist A amounts to medical malpractice. I have
power of attorney to handle my mothers affairs.
The facts are as follows: a 75 year-old female with chronic atrial fibrillation or A-
fib (4+ years) was given a new treatment plan by cardiologist A of anti-arrhythmic drug
(Rythmol) preparatory to cardioversion, for the purpose of restoring the hearts normal
rhythm. I later learned from cardiologist B (and others) that this treatment plan was
completely inappropriate, given the fact that moms A-fib was chronic, 4+ years.
Chronic A-fib does not respond to cardioversion, because after six months or so of
arrhythmia the hearts memory is resistant to change.
Stephen J. Knox, Attorney at Law Page - 2
August 17, 2007

Sincerely,
Neil J Gillespie
o
\JAW OFFICES
VICTOR J. MUSLEH,-JR., P.A.

~
OCALA, FLORID~
VICTOR J. MUSLEH, JR. POST OFFICE BOX 250 HISTORIC

KELLY H. MUSLEH OCALA, FLORIDA 34478-0250 SANDERS-TOWNSEND HOUSE
ANDREA V. STEPHENS Please replY to P. O. Box 907 S.E. THIRD AVENUE
TELEPHONE (352) 732-0600

FACSIMILE (352) 732-5744
www.ocalalaJJ!}er.com
August 22, 2007
Neil J. Gillespie
8092 S W 115 th Loop
Ocala, FL 34481
Re: D/A: 2005 and 2006
Dear Mr. Gillespie:
This letter follows your recent inquiry to my office regarding a medical negligence claim arising
out of the above-referenced date of incident. This will confirm that I did not undertake representation of
your claim. You should note that my refusal does not mean that your case is without merit and I would
suggest that you consult another attorney immediately for a second opinion regarding your rights and
obligations under Florida Law. I would recommend that you contact the Florida Bar Referral Service at 1
800-342-8011.
Meanwhile, it is in1portant for you to understand that your claim is governed by one or more
statutes of limitations. This means that you n1ust file suit or settle within a specified period of time.
Otherwise, your claim might be forever barred. Florida Statutes 95.11 (4)b states that,
an action for medical malpractice shall be commenced within two (2) years
from the time the incidence giving rise to the action occurred or withIn two
(2) years from the time the incident is discovered or should have been
discovered with the exercise of due diligence; however, in no event shall the
action be commenced later than four (4) years from the date of the incident
or occurrence out of which the cause of accident accrued, except that this
four (4) year period shall not bar an action brought on behalf of a minor on
or before the child's eighth (8 th ) birthday .
Additionally, it is imperative that you follow the procedural requirements contained in Florida Statute
766. Please be advised that the limitations period for wrongful death is two (2) years from the date of the
accident. Therefore, please keep this in mind in the event your claim involves the death of a victim of
negligence. Finally, please note that you must follow the requirements of Florida Statute 768 in the event
your claim involves a defendant covered by said statute. It is for this reason that I suggest that you consult
another attorney immediately regarding your rights and obligations under Florida Law.
o
Page 2
Thank you very much for your interest in my firm and I wish you the best of luck with your case.
As always, please free to give my office a call if you have any questions about the foregoing.
VJMjr/tlp
Enclosure (firm brochure)
tI:
. ~'"
1". . . .11 7' . T... . . . , .. 'I ' J"_ a 'W".'$l t ,',
1 a . f" n L7 t>,,',i\
:
~~~PO~
VICTOR J. MUSLEH, JR., P.A.
ATTORNEYS AT LAW
.. .'" 1 , ,(-r. . '
.. ,
'.,:" ' 0".>
,; tJ tfII I,Y
~
~'~~ A!i4$$).:
__ ~ ~~4 ~AiiiiiiiV~
POST OFFICE BOX 250 : ';:) ~ ~ PIl'NV BOWES 'i;
~"g5o~i33403 .~u~~101~ I,i!

OCALA, FLORIDA 34478-0250

~

FROrv1
tvtAtLD 3 ZIPCOD ~4 71
[j
~~
>.-'$:
,~
j
;1
:l~
'I
Neil J. Gillespie ~I
t
8092 S W 115 th Loop

Ocala, FL 34481
::::440 i +::::?5::-1 If'

,,,1'' ', I.. IfII fIlII' I,," II IJ I J.II ".II,I,,,! If If" 1.1
Neil J Gillespie
8092 SW 115th Loop
Ocala, FL 34481
Telephone: (352) 854-7807

August 17, 2007
Victor J. Musleh, Jr., Attorney at Law

P.O. Box 250
Ocala, Florida 34478-1866
Tel: (352) 732-0600
Dear Mr. Musleh,

Victor J. Musleh, Attorney at Law Page - 2
August 17, 2007

Sincerely,
Neil J Gillespie
Page 1 of 1
Neil Gillespie
From: "John Green" <jmg@jgreenatty.com>

Sent: Thursday, August 23, 2007 2:33 PM
Attach: John M Green Jr .vcf
Subject: Med Mal claim
Yourletterdated8/17hasbeenreceived.Wearenotinapositiontoprovideanopinionwithrespectto
whetherthephysicianactedappropriatelyornot.Thefactsofthematteranddamageissuesdonot
meetourrequirementsforacceptingthematterforlitigation.Iwouldsuggestyouseekother
representation.
BeadvisedthatFloridahasatwoyearstatuteoflimitationsformedmalactions.Ifyouwantto
preserveyourmothersrights,youneedtoseekrepresentationassoonaspossible.
J.
_____________________________________________________________________________________________________
This transmission (including any attachments) from the law firm of John M. Green, Jr. PA may contain
information that is confidential and/or subject to the attorney-client privilege or the work product
doctrine. Use or dissemination of this information by anyone other than the intended recipient is
prohibited and may be unlawful. If you have received this transmission in error, please immediately
notify the sender by return email or contact us by telephone at (352)732-9252, and permanently
delete all copies.
12/27/2015
Neil J Gillespie
8092 SW 115th Loop
Ocala, FL 34481
Telephone: (352) 854-7807

August 17, 2007
John M. Green, Jr., Attorney at Law

125 NE 1st Ave., Suite 2
Ocala, FL 34470
Tel: (352) 732-9252
Dear Mr. Green,

John M. Green, Jr., Attorney at Law Page - 2
August 17, 2007

Sincerely,
Neil J Gillespie
McMILLEN LAw FIRM
A PROFESSIONAL AsSOCIATION
SCOTT R. McMILLEN SUITE 140 TELEPHONE: (407) 843-0126
ATTORNEY AT LAW 390 NORTH ORANGE AVENUE FACSIMILE: (407) 849-1267
ORLANDO, FLORIDA 32801

*Admitted to Practice in Florida and Georgia info@ mcmillenlawfirm .com
August 28, 2007
Neil J. Gillespie
8092 SW l1S th Loop
Ocala, FL 34481
RE: Potential medical negligence claim
Dear Mr. Gillespie:
I received your letter on August 22, 2007. Thank you for contacting my firm
regarding a potential medical negligence claim on behalf of your mother.
Unfortunately, I will not be able to take her case.
Before any medical negligence claim can be considered, first we must obtain
copies of pertinent medical records for our own in-house review. If we believe the
information in the records supports the theories of the negligence, I must hire a
medical expert in the same specialty as the potential defendant to determine if he
or she would be willing to testify the treatment fell below the standard of care
and was the direct cause of the injury.
From the information you have provided, it appears your mother suffered
complications from the side effects of taking Rythmol. In retrospect while it
appears this was not an appropriate medication for your mother, proving that it was
negligently prescribed to her for her condition may be difficult. Thankfully, your
mother recovered from the major complications of this adverse event.
I am not saying you do not have a case, btlt that, in my judgment, I cannot
justify the costs of further investigation. Certainly, another attorney may feel
differently about your claim, and we encourage you to seek other opinions. If you
do plan to discuss your claim with other attorneys, please keep in mind that there is
a statute of limitations for medical negligence claims. Any claim that is not filed
within the time required by law is forever barred. The exact date of the running of
the statute of limitations in a medical negligence claim is rarely crystal clear so I
o
Neil J. Gillespie
August 28, 2007
Page 2
would encourage you to call another lawyer immediately, if you wish to pursue
this further.
Thank you again for contacting me, I regret I am unable to assist you and
your mother.
Very truly yours,
Scott R. McMillen
SRM/dlc
r~'" t .'t"WIt"'.ls 'rr ler. . . . . . . . r~rlln :I...... 1Ir......:, .El...... I.. ,r _ ~~'J~ur . "I "'r 1
1 1 t_
,,.
I'
f
~
'
I
McMILLEN
..
I...A.w
A PROPBSSIONAL AsSOCIATION
SUITE 140
FIRM
I I,~
III
1I
.
J . $0.41 .Q
U:", POSTAGE
FIRST-CLASS
FROrv132801
AUG 21 2007
390 NORTH ORANGE AVENUE
stam~
.CX>ITI
ORLANDO, FLORIDA 32801
HrIlH.tB n' Ii'il i! II. ,11'1 II .. till 1.1.11. ~,IIIIIII,I,II.I,I,I i" J! Ii

!
NeH J. G;llespie
3092 S\J'J 1 '~ :,th loaf)
O(~a;a F:L 34l~81 356'7
o ;,.i i ~,:, III! ~'I; ~ I",,' i II.~ i i ~.!!,' I ,11.1.1 1.1 ~ 111.1
j
:~:44~; i +~:~==7 \! Ill. I , ! i J 11 f II. t I! 1111 \ II. f J I! ! , 11. J f JI! 1 I ! j 1 , I. JI,oj

f t, f fJ
-,,~~ "" ,iii i jS

Neil J Gillespie
8092 SW 115th Loop
Ocala, FL 34481
Telephone: (352) 854-7807

August 18, 2007
Scott R. McMillen, Attorney at Law

McMillen Law Firm, PA
390 North Orange Avenue, Suite 140
Orlando, Florida 32801
Tel: (407) 843-0126
Dear Mr. McMillen,

power of attorney to handle my mothers affairs. This is a self-referral from information
I found on your web site.
Scott R. McMillen, Attorney at Law Page - 2
August 18, 2007

Sincerely,
Neil J Gillespie
Martin J. Goldberg Jonathan A. Goldberg
August 30th , 2007
Neil Gillespie
8092 SW 11Sth Loop
Ocala, FL 34481
Dear Mr. Gillespie:
I received and reviewed your letter dated August 17th . First let me say that I am sorry to hear about
what happened to your mother.
The question of whether or not the first cardiologist's treatment of your mother constituted
malpractice starts as a medical question before it becomes a legal question. Florida law requires
an af'fidavit 'from an appropriate physician (in this case another cardiologist) that the treatment your
mother received was below "a reasonable standard of care". This means that not just that the
treatment she received was "contraindicated" but that it was also "unreasonable" and therefore
belowthe standard of care. In otherwords, no "reasonable" cardiologist would have recommended
the pursuit of such a course of treatment.
The second signi'ficant issue in this and any potential malpractice issue are the damages.
Malpractice cases are the most costly ones to pursue and generally cost many tens of thousands
of dollars in what we call "out of pocket expenses". Those are expenses not covered by the
attorney's fee percentage but expenses that go towards developing the case and primarily for
expert opinions and testimony which is very expensive. This means even cases where there is
provable malpractice only tend to be "worth" pursuing if the damages are very significant. The
primary factors that would be looked at would be medical expenses, overall health and age of the
potential plaintiff, and any long term effect on the potential plaintiff's overall health and quality of
life.
Vvhile I would not agree to represent your mother in this instance, I am not in a position to offer you
a solid opinion on whether or not there is actionable malpractice here. I have though attempted to
let you know the kinds of things that any attorney will look at when determining whether or not they
\;vould be willing to pursue this case
Finally, you should be aware that the Florida statute of limitations is two years from when you knew
or arguably should have known that malpractice occurred. Given the fact that she was under the
care of this other physician in 200S, I would advise that if you are interested in pursuing this matter
legally that you continue to seek the opinion of other attorneys immediately.
Thank you for writing us. We wish you and your mother the best.
I
!
MJG/ap
1013 Southwest Second Avenue Gainesville, Florida 32601
Gainesville (352) 376-1200 Jacksonville (904) 634-1400 Ocala (352) 622-1799
Fax (352) 376-11 06
GOLDBERG
:*:~~ u.s. POSTAGE
LAW OFFICE 1060 PB3565686
1013 S.W. Second Ave . Gainesville. FL 32601 7982S 00 . 41 0 AUG 31 200 7
8823 MAILED FROM ZIP CODE 3 260 1
Martin}. Goldberg
GOLDBERG Attorney at Ldw
Neil Gillespie
ACCIDENTS/INJURY
INSURANCEINEGUGENCE 8092 SW 115th Loop
DISABILITYIWORKERS COMP Ocala, FL 34481
Gainesville (352) 376-1200
Ocala (352) 622-1799
11.11 1111.1,111,11,11111111111
LAW OFFICE Toll Free (800) 367-1201
Fax (352) 376-1106
Main Ofjice-1013 Southwest 2nd Ave. Gainesville, FL32601
=!~ ~+::+ e 1 ..t:::: =$:::.. 7 I.. U ' .. I" .. II .. I.. " II" U,.I,l., II":,,,H, lu. ,:.1:I,t
Neil J Gillespie
8092 SW 115th Loop
Ocala, FL 34481
Telephone: (352) 854-7807

August 17, 2007
Martin J. Goldberg, Attorney at Law

Goldberg Law Office
1013 SW 2nd Avenue
Gainesville, FL 32601
Tel: (352) 622-1799
Dear Mr. Goldberg,

Martin J. Goldberg, Attorney at Law Page - 2
August 17, 2007

Sincerely,
Neil J Gillespie
Piccin
LAW FIRM
(352) 351-5446
JOHN H. PICCIN Fax (352) 351-8057 320'N\V Third ~-\venue
The Florida Bar' Post Office. Bo'f 159
State Bar of Michigan Ocala. Florida 34478..0159
Past President, North Florida Chapter, . \V\V\v.pi~ci~la\~firm.~om
American Board of Trial Advocates
KATHERINE PICCIN GLYNN, OF COUNSEL
September 24, 2007
Neil J. Gillespie
8092 S.W. 115 th Loop
Ocala, FL 34481
Dear Mr. Gillespie:
Upon reflection, I have decided that we cannot undertake a claim on your mother's behalf.
Cardiac cases are very complicated and expensive. There are different types of a-fib, many possible
causes and many different treatments.
Any claim is subject to a statute of lilnitations. This means that any claim mllst be settled
or tiled in court within the applicable statute of limitations, or any claim will be forever barred. If
you still have any idea of pursuing a claim, you should seek the services on another lawyer without
delay.
Thank you for contacting me. I wish you and your mother all the best.
JHP/jah
."7 r '1 ';;,. '! rr' , r "I't r '! r tllrilll.'. '1M "'1'1 1'''1
Piccin ***,~
* * ~ ?
PITNEY BOWES
....
>
it'
LAW FIRM 1 000 u.s. POSTAGE PB3 5 3 0 3 3 6
~20 N\V Third ,\vcnuc
Post (Xl'icc Box 1')9 2203100.410 SEP 24 2007
Ocala, Horida ~44 78-0 I 19 1 5 1 3 MAILED FROM ZIP CODE 34470
Neil J. Gillespie
8092 S.\V. 115 th Loop
Ocala, FI.l 34481
e
:::::~48 i +~:S~ 7 ' 11" 'ff'",,11,,1. .11 11 II J. II all J11111. J.. II J. nIf'"
If If
~
-,....._ 2. hi !" ''',' ;
Neil J Gillespie
8092 SW 115th Loop
Ocala, FL 34481
Telephone: (352) 854-7807

August 17, 2007
John H. Piccin, Attorney at Law

The Piccin Law Firm
320 NW 3rd Ave.
PO Box 159
Ocala, FL 34478
Tel: (352) 351-5446
Dear Mr. Piccin,

John H. Piccin, Attorney at Law Page - 2
August 17, 2007

Sincerely,
Neil J Gillespie
https://www.justice.gov/opa/pr/government-intervenes-lawsuit-against-florida-cardiologist-alleging-unnecessary-peripheral
JUSTICE NEWS
Office of Public Affairs
FOR IMMEDIATE RELEASE Monday, January 5, 2015
Government Intervenes in Lawsuit Against Florida Cardiologist Alleging

Unnecessary Peripheral Artery Interventions and Payment of Kickbacks
The government has intervened in two lawsuits against a Florida cardiologist, Dr. Asad Qamar, and his physician
group, the Institute for Cardiovascular Excellence PLLC (ICE), alleging that Qamar and ICE billed Medicare for
medically unnecessary peripheral artery interventions and paid kickbacks to patients by waiving Medicare
copayments irrespective of financial hardship, the Justice Department announced today.
Performing medically unnecessary procedures puts patients at risk and contributes to the soaring costs of health
care, said Acting Assistant Attorney General Joyce R. Branda for the Justice Departments Civil Division. Todays
action evidences the Department of Justices efforts both to safeguard federal health care program beneficiaries
and to protect public funds.
The lawsuits allege that Qamar and ICE performed excessive and medically unnecessary peripheral artery
interventional services and affiliated procedures on Medicare patients. One of the lawsuits further alleges that
Qamar induced patients to undergo those unnecessary procedures by routinely waiving the 20 percent Medicare
copayment, regardless of the patients financial need.
Physicians should make medical decisions on the basis of their patients needs, said U.S. Attorney A. Lee Bentley
III for the Middle District of Florida. Performing medically unnecessary procedures solely to line a physicians
pockets strains our nations health care system, and can also jeopardize the health and safety of patients. Fighting
Medicare and other health care fraud is one of our offices most important priorities.
The lawsuits were filed under the qui tam, or whistleblower, provisions of the False Claims Act, which permit
private parties to sue on behalf of the government when they discover evidence that defendants have submitted
false claims for government funds and to receive a share of any recovery. The False Claims Act also permits the
government to intervene in such lawsuits, as it has done in these cases. The cases are captioned United States ex
rel. Doe v. Institute of Cardiovasular Excellence, PLLC, ICE Holdings, PLLC, Dr. Asad Qamar, & Dr. Humera
Qamar, Case No. 5:11-CV-406-OC-KRS (M.D. Fla.) and United States ex rel. Taylor & the State of Florida v.
Institute of Cardiovascular Excellence & Dr. Asad Qamar, Case No. 8:14-CV-1454-T-35-EAS (M.D. Fla.)
Physicians who try to enrich themselves and their practices by performing medically unnecessary, invasive
procedures can cause patients very serious health issues, waste millions in taxpayer dollars each year, and
undercut the publics trust in the medical profession, said Special Agent in Charge Derrick L. Jackson of the U.S.
Department of Health and Human Services-Office of Inspector General (HHS-OIG). We will continue to work with
our law enforcement partners to protect beneficiaries and hold health care providers accountable for such
outrageous fraud schemes.
This matter illustrates the governments emphasis on combating health care fraud and marks another achievement
for the Health Care Fraud Prevention and Enforcement Action Team (HEAT) initiative, which was announced in May
2009 by the Attorney General and the Secretary of Health and Human Services. The partnership between the two
departments has focused efforts to reduce and prevent Medicare and Medicaid financial fraud through enhanced
cooperation. One of the most powerful tools in this effort is the False Claims Act. Since January 2009, the Justice
5/14/2017 12:46 AM
https://www.justice.gov/opa/pr/government-intervenes-lawsuit-against-florida-cardiologist-alleging-unnecessary-peripheral
Department has recovered a total of more than $23.3 billion through False Claims Act cases, with more than $14.9
billion of that amount recovered in cases involving fraud against federal health care programs.
The investigation was conducted by HHS-OIG, the Civil Divisions Commercial Litigation Branch and the U.S.
Attorneys Office for the Middle District of Florida. The claims asserted by the government are allegations only and
there has been no determination of liability.
Topic(s): Component(s):
False Claims Act Civil Division
Healthcare Fraud
Press Release Number:
15-002
Updated May 1, 2017
5/14/2017 12:46 AM

Letter To Stephen Muldrow USAFLM Re Dr. Asad Qamar May-12-2017

Încărcat de

Informații document

Titlu original

Drepturi de autor

Formate disponibile

Partajați acest document

Partajați sau inserați document

Opțiuni de partajare

Vi se pare util acest document?

Este necorespunzător acest conținut?

Drepturi de autor:

Formate disponibile

Letter To Stephen Muldrow USAFLM Re Dr. Asad Qamar May-12-2017

Încărcat de

Drepturi de autor:

Formate disponibile

VIA Email and U.S.

Mail May 12, 2017

W. Stephen Muldrow USAFLM

RE: United States v Florida cardiologist Dr. Asad Qamar

Dear U.S. Attorney Muldrow:

Dr. Qamar committed medical negligence/malpractice when he violated a medical standard of

From: "Neil Gillespie" <neilgillespie@mfi.net>

----- Original Message -----

A. Lee Bentley, USAFLM

Paul Wysopal, Special Agent in Charge

Michelle S. Klimt, Special Agent in Charge

RE: United States v Florida cardiologist Dr. Asad Qamar et al.

U.S. Attorneys Middle District of Florida News

U.S. Attorneys Office

Middle District of Florida

FOR IMMEDIATE RELEASE Thursday, June 30, 2016

Updated June 30, 2016

ASAD ULLAH QAMAR

License Number: ME73803

v. CASE NO.: 2014-15189

ASAD ULLAH QAMAR, M.D.,

Petitioner Department of Health files this Administrative Complaint before the

1. Petitioner is the state agency charged with regulating the practice of

Chapter 458, Florida Statutes.

2. At all times material to this Complaint, Respondent was a licensed physician

3. Respondent's address of record is 4730 SW 49th Road, Ocala, Florida 34474.

5. On or about August 29, 2014, Respondent performed a balloon angioplasty

and atherectomy procedure on Patient A.P.

is used to indicate 'intermittent claudication.'

7. Respondent performed a CT scan and angiogram of Patient A.P.'s legs,

8. The balloon angioplasty and atherectomy procedure performed on Patient

A.P. was not medically necessary.

9. Section 456.072(1)(bb), Florida Statutes (2014), provides that performing

or attempting to perform health care services on the wrong patient, a wrong-site

procedure, a wrong procedure, or an unauthorized procedure or a procedure that is

medically unnecessary or otherwise unrelated to the patient's diagnosis or medical

condition is grounds for disciplinary action by the Board of Medicine.

12. On or about August 29, 2014, Respondent violated Section 456.072(1)(bb),

Florida Statutes (2014), by performing or attempting to perform a medically unnecessary

procedure by performing a balloon angioplasty and atherectomy on Patient A.P.

13. Based on the foregoing, Respondent violated Section 456.072(1)(bb),

Florida Statutes (2014), by performing or attempting to perform a procedure that is

an order imposing one or more of the following penalties: permanent revocation or

suspension of Respondent's license, restriction of practice, imposition of an administrative

fine, issuance of a reprimand, placement of the Respondent on probation, corrective

the Board deems appropriate.

SIGNED this day of , 2016

Celeste Phillip, MD, MPH

Respondent has the right to request a hearing to be conducted

Mediation under Section 120.573, Florida Statutes, is not

OTICE REGARDING ASSESSMENT OF COSTS

Respondent is placed on notice that Petitioner has incurred

DATE OF ATT SERV REV

12/06/05 483 01 3311A P MSWM 110 0623 17 DAYS AT 700.00 11,900.00

TOTAL ROOM AND CARE 11,900.00

A FOR-PROFIT, TAX PAYING HOSPITAL LICENSED BY THE

DATE OF BATCH F NDC/CPT-4/

120905 09B707 0712 111106 60977000101 1 PROMETHAZIN 25MG AMP 91.25

A FOR-PROFIT, TAX PAYING HOSPITAL LICENSED BY THE

DATE OF BATCH F NDC/CPT-4/

121605 16B432 0712 124630 4199806 1 MIDAZOLAM 2MG VIAL 105.25

A FOR-PROFIT, TAX PAYING HOSPITAL LICENSED BY THE

DATE OF BATCH F NDC/CPT-4/